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ABSTRACT OF THE DISSERTATION
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Optic neuritis (ON) is an early manifestation in patients of multiple sclerosis (MS), typically
resulting in visual dysfunction. The inflammatory demyelination of the optic nerve in ON closely
resembles pathologies of the rest of central nervous system (CNS) white matter in MS. Since
accumulated axonal degeneration in MS was considered as the potential cause leading to
permanent disability, correlating optic nerve pathology and visual function in ON could be a
model system to investigate the relationship between functional outcome and neuropathology. It
may also present a new way to reflect the disease progression in MS. Various MR techniques
have been used to assess inflammation (inflammatory cell infiltration and vasogenic edema) of
ON, but rarely demonstrated the ability to image cellularity changes non-invasively. Diffusion
MRI measures the Brownian motion of water molecules in the microstructure of biological
tissues. Diffusion tensor imaging (DTI) holds the promise to provide a specific biomarker of
axonal injury and demyelination in CNS white matter by axial diffusivity (the diffusion parallel
to white matter fibers) and radial diffusivity (the diffusion perpendicular to white matter fibers),
respectively. However, DTI assumes a single diffusion tensor model and thus takes an average of

xi

varied diffusion components. In contrast, our recently developed diffusion basis spectrum
imaging (DBSI) resolves the complex diffusion components and provides relatively accurate
directional diffusivities and diffusion component fractions, relating to the detail and accurate
pathological picture of the disease or injury. In the current work, in vivo 25-direction DBSI was
applied to the optic nerve of mice with experimental autoimmune encephalomyelitis (EAE), an
animal model of MS, with visual impairment at onset of ON. Our results demonstrate that
inflammation correlated well with visual impairment in acute ON. DBSI successfully detected
inflammatory cell infiltration and optic nerve white matter pathology in EAE that was consistent
with histology, supporting the capability of DBSI to quantify increased cellularity, axonal injury
and myelin damage in the optic nerve of EAE mice.
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Chapter 1
Introduction
1.1 Multiple Sclerosis
Multiple Sclerosis [1] is an autoimmune disease of the central nervous system (CNS)
primarily targeting myelinated axons of the CNS (Fig 1-1). This disorder is typically diagnosed
in young adults and affects women more than men [2] . MS is named for the accumulation of
scar tissue (sclerosis) around the multiple foci within the brain and spinal cord, inhibiting signals
from CNS to the rest of the body which can cause MS patients to suffer a variety of neurological
disorders in the clinic, involving motor and sensory disorder, disturbance of vision (e.g. blurred
vision and blindness in one or both eyes), coordination, balance, and more [3, 4]. Although the
etiology of MS is not known, the disease’s neuropathology consists primarily of inflammatory
demyelination at lesions in white matter CNS. The pathology is generally caused by invasion of
inflammatory cells into the CNS and destruction of oligodendrocytes and patches of myelin
sheaths and axons in variable degree [5-7] (Fig. 1-2).
Visual dysfunction is, frequently, the first clinical symptom in MS. Around 66% of
patients with MS will have at least one episode of optic neuritis during the disease course
(http://www.nationalmssociety.org/). There are two subtypes of optic neuritis associated with
MS: retrobulbar neuritis (or inflammation of the optic nerve behind the eye) and papillitis (or
inflammation of the optic disc) of which the former is the most commonly associated with MS
[8].
Motor dysfunction also frequently develops during the MS disease time course. Based on
disability, four clinically defined types of MS (Fig. 1-3) have been classified using standard
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neurological exams or extended disability status scoring [9]. Relapsing-remitting MS (RRMS),
the most common type (~50% of the cases), is clinically characterized by recurrent attacks
followed by either partial or total recovery from of neurological function, however these patients
eventually develop a gradual neurological decline with repeated episodes of CNS inflammatory
insult. Secondary progressive MS (SPMS) is the second most common type of MS (~30% of the
cases) which may initially resemble RRMS before moving into a stage of progressive
impairment. Primary progressive MS (PPMS) (~10% of the cases) begins as a gradual decline in
function without remitting stages over the course of the disease. The fourth MS type, progressive
relapsing MS (PRMS) (~5% of the cases) involves both progressive impairment and relapse
from onset of the symptoms. The overall disease time course varies widely across these four
classifications and even within each classification due to individual variability.

2

Figure 1–1 The myelinated axon in white matter of central nerve system. The long cylindrical
shape of axon is wrapped tightly by myelin sheath.
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Figure 1–2 (A) Summary diagram of axonal response during and after transection at acute stage,
including (1) normal myelinated axons, (2) demyelination occurs due to immune-mediated
process, and (3) the distal end of the transected axon rapidly degeneration. (B) degeneration of
demyelinated axons process at chronic stage, including (1) most axons survive after
demyelination and redistribute Na+ channels, (2) chronically demyelinated axons exhibit slowly
progressive swelling, (3) axons eventually degenerate.
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Figure 1–3 Types of multiple sclerosis (left to right; top to bottom): relapsing-remitting,
secondary progressive, primary progressive, and progressive relapsing.
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1.2 Experimental Autoimmune Encephalomyelitis
Experimental Autoimmune Encephalomyelitis (EAE) is the most intensively used animal
model system for studying MS pathologies [10]. EAE models mimic many of the clinical and
neuropathological aspects of human MS, such as motor disability, visual dysfunction, as a result
of CNS inflammatory demyelination. A major difference between MS and EAE is that the latter
requires an external immunization step to develop. EAE is induced by injecting genetically
susceptible animal strains with CNS myelin proteins such as myelin basic protein (MBP), myelin
oligodendrocyte glycoprotein (MOG), and proteolipid protein (PLP). The innate immune system
recognizes the introduced foreign matters as pathogens, and because native cells in the brain,
spinal cord, and optic nerve express the same protein(s), the immune system attacks these
proteins within the CNS. Thus, a MS-like disease can be induced in animals by stimulating
innate T-cells to target myelin proteins. Similar to MS, EAE is also heterogeneous and
influenced by the selected antigens, species and the genetic background.
Rodent EAE models can be induced on many different genetic strains with different
myelin proteins such as PLP-EAE in SJL mice and MOG-EAE in C57BL/6 mice, and in rats.
Each model may have different disease progression and proposed mechanism [11-15]. Among
varied myelin proteins, MOG antigen tends to cause optic neuritis because of the high abundance
of this protein inside the optic nerve [16]. The Inflammatory cell attack against the MOG
autoantigen of the optic nerve is presumed to be the initiator in the sequence of events that
ultimately lead to optic nerve damage. EAE models develop both encephalomyelitis and optic
neuritis [16]. Furthermore, C57BL/6 mice immunized with MOG have been demonstrated to
mimic many disease stages with pathological and clinical features of MS [12, 17]. MOG-induced
EAE models are routinely used to study phenomena in the relapsing-remitting and chronic stages
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of the disease. Typically, mice in the acute stage (around 2 weeks post-immunization) exhibit an
inflammatory response in optic nerve, spinal cord, and brain, which then leads to demyelination
and axonal injury. EAE optic neuritis can produce a range of visual impairments, from mild to
complete blindness in the affected animal [13]. Since disease events and relationships with
functional outcomes have been extensively characterized in EAE, it is a good model for studying
pathophysiology of MS and associated optic neuritis. Animal model have been very useful in
developing and validating in vivo MRI techniques with histological assessment, which is not
possible in human studies. In this study, MOG-EAE in C57BL/6 mice was used as an
inflammatory demyelinating model of MS.

1.3 Optic nerve morphology and visual function
Optic nerve pathology may develop after just a single attack of optic neuritis [18].
Persistent or permanent vision loss has been shown to result from accumulated damage to the
optic nerve and retina. Pathological consequences at the retina can include retinal nerve fiber
layer (RNFL) thinning, retinal ganglion cell (RGC) loss, and decreased macular volume [19, 20].
In general, post-mortem histological examination of optic nerve and retina is used to determine
the degree of injury and the pathological mechanism at different disease stages.
As noted in Section 1.2, the mechanism of neurodegeneration in EAE ON differs
depending on the particular EAE model with inter-animal variability within each model. For
example, MOG-induced EAE models described in the literature in C56BL/6 mice are reported
to develop optic nerve inflammation prior to RGC loss [12, 13]. However, axonal irregularity or
degeneration may also coincide with cell infiltration prior to demyelination [13]. In contrast,
inflammatory-cell-infiltration-induced demyelination secondary to direct RGC loss has been
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revealed in a rat model of MOG-EAE [14]. Since histology studies of tissue morphology are
accepted as a gold standard for validation, it is essential to develop a systematic and objective
approach to accurately quantify histopathology in disease or injury. Our newly-developed, noninvasive MRI approach to studying optic nerve pathology is detailed and examined in Chapter 2.
Several techniques are used to examine changes in function of optic nerve or retina in
mice with optic neuritis. Visual evoked potential (VEP) measures the gross electrical potential at
the level of the visual cortex in response to visual stimulus, reflecting optic pathway conductivity
[13, 21]. A delayed VEP latency is presumed to represent demyelination of axons in the optic
nerve. Optokinetic tracking response (ORK) is an objective assessment of visual acuity (VA)
based on evaluation of mouse head tracking movement similar to optikinetic nystagmus in
humans, reflecting the function of visual pathway [22, 23] (Fig. 1-4). Electroretinography [24]
recording reflects the activity of neuronal cells within the retina resulting from visual stimulation
[25, 26]. In the present study, mouse visual function was evaluated in acute EAE optic neuritis
using OKR as detailed in chapter 4.
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Figure 1–4 Visual function was assessed by visual acuity (VA) using a Virtual Optometry
System (OptoMotry, CerebralMechanics, Inc., Canada). OptoMotry apparatus in side view (A)
and top view (B). In brief, a mouse was placed on the platform in a closed chamber with four
computer monitors arranged in a square. Waiting until mouse stopped moving, a virtual cylinder
of a grating with an adjustable spatial frequency (at 100% contrast, 12 degree/sec) was projected,
centering in mouse head and moving in either clockwise or counter-clockwise direction (C).
Mouse was observed through a camera and mouse visual threshold was determined by increasing
the spatial frequency until mouse head cannot track the cylinder rotation, judging that mouse
cannot see the grating. In addition, mouse head tracks the virtual rotation if seeing the grating
(D). Visual function was reflected by VA, the highest spatial frequency mouse can see, in a unit
of cycle/degree (c/d). Mice track in one direction with each eye, thus individual mouse eye
vision could be assessed by applying specific rotating direction.
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1.4 Imaging optic neuritis
Optical coherence tomography (OCT), a relatively new technique, based on patterns of
infra-red light reflected from the back of the eye, detects structural changes in RNFL (reflecting
optic nerve fiber), thickness of other retinal layers and macular volume, which serve as an
imaging outcome [27, 28]. However, OCT is limited in its applicability for direct studies of
optic nerve. Magnetic resonance imaging (MRI) techniques allow direct imaging of the optic
nerve and have shown great potential to estimate the underlying pathology in optic neuritis. For
example, increased gadolinium-contrast enhanced MRI determination of optic nerve volume in
EAE reflects breakdown of blood nerve barrier, suggesting optic nerve inflammation [29, 30].
Cell infiltration, another aspect of inflammation, in MS has been shown to occur early by ultrasmall particles of iron oxide (USPIO) enhanced MRI [31]. Optic nerve swelling (or increased
optic nerve mean area) was detected in acute optic neuritis by short tau inversion recovery MR
imaging, suggesting optic nerve inflammation [32]. Furthermore, diffusion tensor imaging (DTI)
analysis has demonstrated that decreased axial diffusivity and increased radial diffusivity
correlate well with axonal injury and demyelination of the optic nerve in chronic EAE, providing
quantitatively non-invasive biomarkers of white matter injuries in CNS [15].
The assumption of Gaussian diffusion, inherent in the DTI model, limits its ability to
provide an accurate and detailed picture of disease pathology in acute EAE optic neuritis. For
instance, inflammation coincident with other pathological changes is responsible for a clear nonGaussian diffusion component. Our recently-developed diffusion basis spectrum imaging (DBSI)
enables us to resolve the contribution of this non-Gaussian signal component [33]. A detailed
comparison of diffusion MRI using both DTI and DBSI model analyses are presented later in
this study (see Chapter 3 and 4).
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1.5 Diffusion MRI
In the following sections, the principles of diffusion MRI (dMRI) are discussed. dMRI relies on
random diffusional motion of water molecule to reflect tissue contrast and is highly associated
with anatomical microstructure. At the end of this section, several current working models are
also introduced.

1.5.1 Diffusion in spin echo NMR and MRI
In 1H MRI, we are usually concerned with the behavior of water protons. Protons placed
in an applied homogeneous magnetic field, B0, will precess about the direction of the applied
field, at the Larmor frequency, according to equation [1-1] (Fig. 1-5 A). In tissue, the total vector
sum of proton dipoles can be represented as a single vector, the so-called magnetization, that
precesses about the direction of B0 [34] (Fig. 1-5 B).

1

1

Diffusional motion in an inhomogeneous magnetic field induces phase incoherence in the
macroscopic magnetization causing signal attenuation. The effect of diffusion on the MR signal
was first addressed in 1950 by Hahn [35]. Carr and Purcell quantitatively analyzed the diffusioninduced spin-echo-signal attenuation in the presence of a constant gradient, which produces a
linear spatial variation in Larmor frequency [36]. The resulting spin-echo amplitude is described
by:
S nTE

exp

Dγ G TE
12n

1

2

where TE is echo time, D is diffusion coefficient,  is gyromagnetic ratio, G is steady gradient,
and n is number of the echo in a multiple-spin-echo experiment.
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However, the diffusion measurement using constant gradients is not optimal for MRI
studies. The constant gradient would affect the slice-selection profile significantly and also
would affect MR signal readout, causing significant reduction of signal-to-noise ratio. In 1965,
Stejeskal and Tanner introduced MR diffusion measurements using a pair of

pulsed-field

diffusion-sensitizing gradients [37]. The spin echo sequence with a diffusion sensitizing gradient
pair is shown in Fig. 1-6. Stejskal and Tanner initiated their work from the Bloch equations with
a diffusion term, as initially proposed by Torrey [38].
In the presence of magnetic field, the macroscopic magnetization experiencing both T1
and T2 relaxation is quantitatively described using empirical vector equation introduced by Bloch
[39, 40]:
dM r, t
dt

γM r, t

In this equation,

M x

B r, t

M y
T

M –M z
T

 is the gyromagnetic ratio, M r, t

1

M x

M y

3

M z is the net

magnetization, B r, t is the externally-applied magnetic field (which may vary as a function of
time and/or position), M is the equilibrium state magnetization, T1 is spin-lattice relaxation time,
and T2 is spin-spin relaxation time. The differential equation [1-3] is further generalized by
including Torrey’s self-diffusion term [38], with the result:
dM r, t
dt

γM

M x

B r, t

M y

M –M z
T

T

∙ D M

1

4

Here D is diffusion coefficient. Torrey showed that if diffusion is isotropic, the equation [1-4]
can be rewritten in an alternate, slightly simplified form as:
dM r, t
dt

γM

B

M x

M y
T

M –M z
T

12

D

M

1

5

Stejeskal and Tanner started their derivation from this assumption of isotropic diffusion.
First Stejeskal and Tanner considered complex transverse magnetization as
m

M

iM

1

6

1

7

1
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then, the non-diffusion related term was eliminated by introducing equation [1-7]
m

 exp

iω t

t/T ,

yielding equation [1-8]
d
dt

iγ r ∙ G 

D



In equation [1-8], G is the applied magnetic field gradient Stejskal and Tanner assumed that the
values of  immediately after 90 RF pulse is constant, which is S in equation [1-9] and there is
no additional phase accumulation during application of the 180 RF pulse. Then in the absence
of diffusion, the equation [1-8] can be rewritten.


S exp

iγr ∙ F

2H t

τ f

1

9

In equation [1-9], H is the Heaviside step function, τ is half-echo time in the spin-echo
sequence (Fig. 1-6), and F and f are given as follows:
F

G t dt′ and f

F

1
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To solve the equation [1-8] in the presence of diffusion Stejeskal and Tanner assumed that the
solution to be the form of equation [1-9] and the S is to be function of time, S(t). Then S(t) at the
echo time in spin-echo pulsed field gradient pair is expressed as equation [1-11]
ln

S TE
S 0

Dγ

F dt

4f ∙

F dt

13

4f TE

1
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In spin-echo diffusion experiments, the extent of the sequence-specific signal- attenuation is
described by its b value (in ms/µm2). Using this compact notation, equation [1-11] is rewritten
as
ln

S b
S 0

bD.

1

12

It is readily seen that the b-value depends on the pulsed-field-gradient amplitude, duration, and
the time between the two pulsed-field gradients. For a pair of square gradient lobes of the same
amplitude, G (e.g., Fig. 1-6) the b value is given by
b

γ G δ

∆

1

3

13

Equations [1-12] and [1-13] are the key results of the famous work of Stejskal and Tanner [37].
These equations hold for conditions of non-bounded isotropic diffusion.
As shown in equation [1-10] and [1-11], the b-value is directly related to the amount of
phase of the ensemble of magnetization, which is mostly integral part of equation [1-11]. This
means that the applied diffusion sensitizing gradient shape affects consequent b-value. If the
diffusion sensitizing gradient pair does not consist of square pulses, the b-value needs to be
modified. For example, in the case of half-sine-shaped diffusion gradients (Fig. 1-7), the b value
is given by
b

4
γ G δ
π

∆

4

1

14

1
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and for a trapezoidal-shaped gradient pair, the b value is given by
b

γ G δ

∆

3

30
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where  is the ramp time [41]. Note that equation [1 – 15] becomes equation [1 – 13] if  is
negligible.
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Figure 1–5 Each water proton is considered as a spinning sphere with charge and mass and
precesses about the direction of applied magnetic field B0 (A). In tissue, tons of protons precess
could represent as a single vector, so-called magnetization (B)
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Figure 1–6 The Stejskal-Tanner Pulsed-Gradient Spin-Echo sequence with square-wave
diffusion-sensitizing gradients. G - gradient strength,  - duration of diffusion sensitizing
gradient, - time interval between diffusion-sensitizing gradient pulses, RF – radio frequency to
excite nuclear spin, and DSGP – diffusion sensitizing gradient pair
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Figure 1–7 The Spin-Echo sequence with non-constant gradient amplitude. G -gradient strength,
 -duration of diffusion sensitizing gradient, - time interval between diffusion sensitizing
gradient pair, -ramp time
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1.5.2 Apparent diffusion coefficient and anisotropy
Isotropic diffusion, exhibited in pure liquid, is sufficient to describe transport properties
resulting from random thermally-induced collisions of molecules. However, Tanner found that
isotropic self-diffusion could not fully describe particle motion in in more complex
heterogeneous media like living tissue [42, 43]. Tanner introduced the concept of the apparent
diffusion coefficient to explain the observed diffusivity in complex media. The apparent
diffusion coefficient (ADC) is the diffusivity which would be calculated based upon the
assumption of an isotropic Gaussian distribution of molecular displacements. Yet it didn’t take
long time to have reports on non-isotropic diffusion observation in biological tissue. The most
distinct diffusion phenomenon in biological tissue compared to pure liquid is anisotropy.
Cleveland et al, observed anisotropic diffusion in biological tissue in diffusion NMR [44]. Using
Stejeskal and Tanner’s diffusion measurement methodology, diffusion weighted imaging (DWI)
studies reported that the observed ADC was affected by the orientation of the tissue with respect
to the diffusion sensitizing gradients and is now well-appreciated [45, 46].
To evaluate the anisotropy of living tissue using diffusion magnetic resonance imaging,
Basser, Le Bihan, and Mattiello introduced the tensor matrix idea into Stejeskal and Tanner’s
diffusion equation, resulting in a tensor D instead of scalar D.

The DTI analysis requires

acquisition of a series of DWIs [41, 47, 48]. In diffusion tensor treatment, the diffusion equation
[1-12] is now expressed as follows:
S b
S 0

exp

b D

1
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where in bij is i-jth component in the b matrix and Dij is i-jth component of the apparent diffusion
tensor. The diffusion tensor analysis produces additional parameters which are used to describe
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diffusion properties. From the diffusion-tensor matrix the eigenvalues (1, 2, 3) and
eigenvector (1, 2, 3) can be calculated (Fig. 1-8). 1 and 1 represent the principal eigenvalue
and eigenvector, respectively. The size of diffusion ellipsoid size is estimated by Trace of D.


Tr D





3

1
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The magnitude of deviation of diffusion from being purely isotropic is estimated by variance of
the eigenvalues.
Var D






3

1
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The anisotropy of the diffusion ellipsoid is quantified in terms of fractional anisotropy (FA) or
relative anisotropy (RA) - quantities which are known to be rotationally invariant [49].
FA

RA

Var D

3
√2





1
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1

20



Var D

The anisotropy indices have been used to reflect microstructure of white matter [50, 51]. In
addition, the principal eigenvalue (1 or λ║, axial diffusivity) and the mean of the other two
eigenvlaues ((2 +3)/2 or λ, radial diffusivity) have been used to detect abnormal white matter
in various studies [51].
The application of diffusion tensor imaging has been extended to DTI fiber tractography.
The basic idea of DTI tractography is provided by Basser [41], which is that the eigenvectorrelated principal eigenvalue is parallel to the major fiber direction in an image voxel. With
certain thresholds on anisotropy and angle between two adjacent principal eigenvectors, DTI
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tractography has been used to provide reasonably accurate maps of the major white matter tracts
[52-54]. The use of DTI has been mainly focusing on CNS.
Due to the complex structure of CNS tissue, the diffusion-sensitizing gradient directions
and magnitude, or so called diffusion scheme requires optimization. Sampling diffusion
properties with a scheme employing a large set of spatially-distributed diffusion encodings
would provide for the most precise mapping of diffusion indices in CNS. However, the
implementation of overly elaborate diffusion schemes is limited by practical limits of the
required data acquisition time. In previous work, Derek Jones has extensively studied the
optimized diffusion scheme [51]. In the current work we focus primarily on comparison of two
diffusion schemes for ex vivo studies (99 and 25 directions) and implement the 25-direction
scheme for in vivo studies (See chapter 3).
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Figure 1–8 The diffusion ellipsoids and tensors for isotropic unrestricted diffusion, isotropic
restricted diffusion and anisotropic diffusion are shown (A). Fiber tracts have an arbitrary
orientation with respect to scanner geometry (x, y, z axes) and impose directional dependence
(anisotropy) on diffusion measurements (B, top left). Anisotropic diffusion ellipsoid with
orientation characterized by three eigenvectors (1, 2, 3) and shape characterized by three
eigenvalues (1, 2, 3) (B, top right) which can be calculated by diagonalizing the diffusion
tensor (D) (B, bottom).
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1.5.3 Effect of imaging gradients on b-value
It is inevitable that magnetic field gradients other than those required for diffusionweighting, must be employed for MR imaging. The requisite imaging gradients encode for
position in the three cardinal imaging directions: slice selection, phase encoding, and readout.
The imaging gradients produce additional diffusion-weighting. Fig. 1-9 shows spin-echo
diffusion experiment scheme with an additional gradient for spatial information, which is
frequency-encoding for one-dimensional profile image. In Fig. 1-9 A, one sees readily that there
are two different diffusion sensitizing gradient pairs, d and f. Thus, the additional imaging
gradient imparts its own contribution to the total b value of the measurement:
b

γ G δ

∆

δ
3

1
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For a complete description of the diffusion-sensitization produced by the imaging sequence and
most accurate diffusivity estimates, one needs to explicitly account for the contributions made by
these imaging gradients. There are strategies that can be employed to minimize the contribution
of phase-encoding gradients (e.g., Fig. 1 – 9 B, wherein the prephasing frequency encoding
gradient is moved to right next to main frequency encoding gradient). In this case, the f is equal
to f and the effect of bf on the diffusion calculation is minimized. Unfortunately, redesigning of
diffusion sequence doesn’t provide absolute solution for accurate diffusion measurement in the
presence of imaging gradients. Thus one needs to consider interactions between all gradients
[47]. In addition to imaging gradient for spatial encoding, MR diffusion imaging often requires
large crusher gradients to minimize stimulated echoes caused by imperfect 180 RF pulses. Fig.
1-10 shows 2 dimensional spin-echo diffusion sequences with crusher gradient. As shown, there
are three major interactions between gradients, which are 1) between diffusion sensitizing
gradients, 2) between imaging gradients, and 3) between imaging and diffusion sensitizing
22

gradient. Surely, the main diffusion sensitivity b-value is produced by the diffusion-sensitizing
gradients pair. In general, the crusher gradient pair produces 2nd major b-value, about 0.1
ms/µm2. In the work presented in this study, all three interactions between gradients were taken
into account to calculate b-value.

23

Figure 1–9 The effect of spatial encoding gradient on diffusion measurement.
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Figure 1–10 Two dimensional spin-echo diffusion sequence with crusher gradients. The white
are diffusion sensitizing gradients. The gray are imaging gradients for spatial encoding. The red
are crusher gradients.
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1.5.4 Biophysical model analysis of non-Gaussian diffusion
In general diffusion MR study is based on Gaussian distribution of diffusion
displacement. However we have seen that diffusion attenuated signal intensity varies with
respect to the angle between diffusion sensitizing gradient direction and fiber orientation in
section 1.5.2 Non-Gaussian diffusion behavior, as measured experimentally in brain tissue [55,
56] and optic nerve [57, 58] is most pronounced with strong diffusion sensitization. It has been
observed that the relationship between b-value and diffusion signal deviates from
monoexponential behavior if b the value exceeds ~1 ms/µm2 [56, 57]. This non-Gaussian
behavior was first interpreted in terms of contributions of fast and slow diffusing components
using biexponential analysis. In earlier literature, the extracellular space was often suggested to
correspond to the fast-diffusing component whereas the slower diffusion was ascribed to
intracellular space [56, 59, 60].
ln

S b
S 0

f

exp

bD

f

exp

bD

, and f

f

1

1
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in which f and D are the volume fraction and diffusion coefficient, respectively. Regardless of
controversy over the physical interpretation of this deviation from monoexponential diffusion
signal behavior [56], the multi-exponential analysis allows us to examine the microstructure of
CNS in more detail than the Gaussian basis DWI or DTI.
Besides the presence of different diffusion compartments, it is also believed that
microstructural barriers producing restricted or hindered diffusion may contribute to nonGaussian signal behavior. Assaf and Cohen experimentally showed that the mean displacement
of fast component linearly increased with diffusion time whereas the mean displacement of slow
component reached a plateau regardless increase of diffusion time [61, 62]. Assaf et al. also
showed that diffusion displacement of slow diffusion component slightly increased with
26

reduction of physical barrier [63, 64], showing restricted diffusion in CNS. Evidently cell
membrane and organelles are most important consideration factor in morphology-based
biophysical modeling of the diffusion-weighted signal in white matter. In general, an assumption
of restricted diffusion inside of impermeable axon and hindered diffusion in the extracelluar
space is made for modeling water diffusion in white-matter structures [65-68]. Another
important factor in modeling is the presence of glial cells which are believed to contribute an
isotropic restricted diffusion component [57]. Interestingly, most biophysical modeling rarely
models this factor [65, 66] or discards the importance of glial cells by assuming that water in
glial cells are in fast exchange with the extracellular space [68]. Our recently-developed DBSI
multi-compartment model computes the restricted isotropic diffusion signal component,
providing a biomarker of cellularity [33].

1.5.5 Suggested working model
DWI and DTI have been widely used to investigate MS patients and rodent EAE models
in an effort to account for contributions made by underlying pathology, including inflammation
and white matter injury [1, 15, 17, 69-73]. Literature reports have demonstrated that decrease
axial diffusivity (λ║) and increase radial diffusivity (λ) correlate well with axonal injury and
demyelination, respectively (Fig. 1-11) [15, 17, 74]. However, as mentioned in above, the
Gaussian diffusion assumption of DTI limits its ability to resolve non-Gaussian aspects of tissue
water diffusion. Underestimation of white matter anisotropy in DTI can be caused by crossing
fibers, CSF contamination, cell infiltration, edema, tissue loss, etc. [75, 76]. In a microscopically
complex diffusion environment, the simplifying assumptions inherent in DTI may cause
misleading results.
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DBSI has been demonstrated to accurately detect and quantify crossing fibers, axonal
injury, demyelination, and inflammation-associated cell infiltration and edema [33]. The key
concept is that DBSI models white matter diffusion as a linear combination of multiple discrete
anisotropic diffusion tensors describing myelinated axonal tracts and a spectrum of isotropic
diffusion describing restricted (cells), non-restricted (extra-axonal space, edema space, and
cerebrospinal fluid) diffusion components outside of axonal tracts (Fig. 1-12).
For assessment of acute EAE optic neuritis, the neuropathology may involve coexisting
inflammation-related cell infiltration, edema, axonal injury, and demyelination in optic nerve.
We will see that the DBSI model analysis, which includes terms that can account for this
potentially complicated microenvironment, provides a superior description of water diffusion
behavior in acute-stage EAE optic neuritis. In addition, DTI analysis of the same data was
performed for valuable comparisons between interpretations yielded by the two types of
analyses. (Detailed in Chapter 4)
One potential issue in DBSI is relatively lengthy scan time for in vivo animal study.
Application of a time-efficient reduced diffusion scheme without compromising the data quality
will be examined in Chapter 3.
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Courtesy from Dr. Matt Budde
Figure 1–11 Directional diffusivities in white matter injury. Normal myelinated axon has larger
axial diffusivity (λ║, diffusivity along the fiber) than radial diffusivity (λ, diffusivity crossing
the fiber). However, demyelination will cause an increased in radial diffusivity, whereas axonal
injury results in a decrease in axial diffusivity. Directional diffusivities provide specificity to
underlying pathology. Noted that anisotropy (FA) is decreased as well in both situations.
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Courtesy from Dr. Tsang-Wei Tu

Figure 1–12 DBSI multi-compartment model computes anisotropic, restricted, and nonrestricted isotropic diffusion components, reflecting myelinated axon, cellularity, and extraaxonal and extracellular space, respectively.
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Chapter 2
Quantitative analysis of immunohistochemical staining

2.1 Introduction
Diffusion magnetic resonance imaging has shown potential to reflect microstructure in
the central nervous system (CNS) of living subjects in both preclinical and clinical applications
[1-4]. In particular, white matter consisting of coherently-bundled long cylindrical axons
wrapped tightly by myelin sheaths is characterized by a high anisotropy in diffusion maps, Fig. 2
– 1 [5, 6]. In addition, there have been many reports in the literature suggesting that diffusionimaging-derived parameters may reflect pathophysiology of white matter in cases of
neurodegenerative disease or injury [7, 8, 2, 9-13]. Recently, diffusion basis spectrum imaging
(DBSI) was developed for identifying cellularity in white matter [14, 15]. Even though diffusion
imaging may reflect morphology or pathophysiology of white matter non-invasively, the
observed in vivo or even ex vivo MR findings require accurate and precise validation.
Postmortem immunohistochemical (IHC) staining is a gold-standard methodology for identifying
and quantifying neuropathology (http://www.nsh.org). IHC is often used to validate in vivo MRI
findings on the CNS, especially white matter [16, 14, 17-21].
In this study, we utilized phosphorylated neurofilament (SMI-31, intact axon), myelin
basic protein (MBP, myelin sheath), and 4’, 6-diamidino-2-phenlindole (DAPI, nuclei) IHC
staining as a reflection of integrity of mouse optic nerve. Following staining for the relevant
proteins of interest, IHC data should be analyzed quantitatively for validation of in vivo MR
data. Enumeration of the positive signals in IHC staining is commonly used to provide
quantitative measurements. However, most counting is done manually or with limited
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automation. Thus, accurate and, most importantly, objective quantitative method to examine
histological findings is critical to validate MR findings. In this chapter, objective and reliable
quantification methods for various IHC have been addressed.
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Figure 2–1 The visual system and structure of optic nerve. The visual information received in
cell body is transported through myelinated axon (A). The anatomical structure optic nerve in
axial plane is clearly seen (B). The donut-ring shaped myelin sheaths wraps around axon tightly.
Panel A: http://www.vanderbilthealth.com/eyeinstitute/23604
Panel B: Nicholls, John G, Martin, Robert A., Wallace, Bruce G., Fuchs, Paul A. From Neuron
to Brain. 2nd ed. Sunderland, MA: Sinauer Associates, 2001. 327. Print.
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2.2 Tissue preparation and IHC staining
IHC encompasses a range of staining methods to detect specific antigens, mostly proteins,
by interaction between antibody and exploring the principle antibody (See Fig. 2 – 2 A) [22-25].
Fluorescent molecules (or fluorophores) are frequently used as labels in antibodies to reflect IHC
staining effect. In brief, the electrons of fluorophore absorb energy from excitation light and reemit light by a longer wavelength (Fig. 2 – 2 B) due to energy dissipation of surrounding
molecule interaction.
At the end of in vivo MRI study (described further in Chapter 4) animals underwent
cardiac perfusion fixation with 0.01M Phosphate buffered saline (PBS, Sigma-Aldrich, MO,
USA) followed by 4 % paraformaldehyde (PFA, Sigma-Aldrich, MO, USA). The volumes of
PBS and PFA were determined by body weight of animal in 1ml/g ratio to avoid over fixation,
which may damage tissue. After perfusion/fixation, all tissue underwent over-night postmortem
fixation in 4 % PFA. Then the harvested tissues were embedded in paraffin wax blocks and
sectioned into 5-m-thick slices using a microtome. IHC staining protocols were carried out
according as described previously [26-29]. Briefly, sectioned slices were deparaffinized and
rehydrated to facilitate binding of antibodies and then blocked by the solution mixed with 1%
bovine serum albumin (BSA, Sigma-Aldrich, MO, US) and 5% normal goat-serum solution
(Invitrogen, CA, USA) for 20 minutes at room temperature to prevent non-specific binding and
to increase antibody permeability. Next, slices were incubated at 4˚C overnight in monoclonal
anti-phosphorylated neurofilament antibody (SMI-31, 1:1000, Covance, NJ, USA) or rabbit
myelin basic protein antibody (MBP, 1:1000, Sigma-Aldrich, MO, USA) to stain for intact axons
or myelin sheaths, respectively. After rising, goat anti-mouse IgG and goat anti-rabbit conjugated
Alexa 488 (1:800, Invitrogen, CA, USA) were applied to visualize immunoreactivity of
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phosphorylated neurofilament and myelin basic protein. Finally, slices were covered using
Vectashield Mounting Medium with 4’,6-diamidino-2-phenylindole (DAPI) (Vector Laboratory,
Inc., CA, USA). After each staining, digital images were taken with a fluorescence microscope
(Nikon Eclipse 80i, USA), using identical light intensity and exposure time settings. Identical
intensity scales were used for all digital images. The captured images were saved as 16-bit gray
scale images for quantitative analysis. Quantification of IHC-positive staining was performed
using ImageJ 1.46r (http://rsbweb.nih.gov/ij/) and related plugins. The digitally-captured images
were loaded as gray scale with black background, zero value.
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Figure 2–2 Immunohistochemical (IHC) stain. The mechanism of IHC stain is shown in a with a
cartoon figure (A). The primary antibody interacts with target antigen protein whereas the
secondary antibody binds to the primary antibody. Fluorescent molecules (the red or green color
star symbols) are frequently incorporated into secondary antibodies as a label antigen-antibody
interaction. Panel B shows the energy-level diagram for the fluorescent moiety. Excitation of
the fluorophore-labeled tissue sample with a specific wavelength of light results in a spatiallyvariable fluorescence emission at a longer wavelength. The spatial distribution of fluorescence
emission in the micrograph acquired at this longer wavelength is interpreted as reflecting the
distribution of the target antigen in the tissue sample.
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2.3 Quantification of nuclei using DAPI
4',6-diamidino-2-phenylindole (DAPI) was used to stain cell nuclei in optic nerves. A
representative DAPI-stained mouse optic nerve is shown in Fig. 2 – 3. In general DAPI stain is
highly prominent, so the signal-to-noise ratio (SNR) between DAPI positive objects vs.
background is quite high (see Fig. 2 – 3) enabling direct threshold without further postprocessing. To select only DAPI positive nuclei, an iterative procedure based on the Isodata
threshold algorithm was used [30]. This algorithm defines the threshold as threshold = (average
background + average objects)/2. First, 16-bit gray scale image was converted into 8-bit and then
image was divided into object and background by taking an initial threshold the averages of the
pixels above threshold and pixels at or below threshold are computed. After this, the averages of
those two averaged values were computed. The threshold was again incremented and the process
was repeated until the threshold was larger than the composite average reaching the condition,
threshold = (average background + average objects)/2. The Isodata threshold was performed on
8-bit gray scale. Once thresholds were determined, positive objects were quantified using ImageJ
particle analysis, http://rsbweb.nih.gov/ij/docs/menus/analyze.html, See Fig. 2 – 4. Using the
addressed protocol, DAPI-positive nuclei were successfully enumerated showing severity of
pathology of EAE mouse optic nerve, severe inflammation induced cell infiltration (Fig. 2 – 5).

43

Figure 2–3 DAPI stain on mouse optic nerve and one dimensional intensity profile. Nuclei of
cell bodies in mouse optic nerve are shown with DAPI stain at 20x magnification (A and B). The
one dimensional intensity profile is shown for DAPI positive nuclei (C, solid line in A) and
background (D, dashed line in B).
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Figure 2–4 Quantification of DAPI uses iterative selection threshold. The intensity histogram of
whole optic nerve having DAPI stain (A) is shown in B. DAPI positive nuclei intensity is distinct
from background signal (B). Panel C shows object above threshold obtained from IsoData
algorithm and panel D shows the final product of quantification.
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Figure 2–5 Representative DAPIs on mice optic nerves and quantified nuclei map. The raw
DAPI images (20x) of mouse optic nerves having mild (B) and severe (C) inflammation
including control (A) are shown. Panel D (control), E (mild), and F (severe) are quantified DAPI
positive nuclei maps, and results show 120, 179, and 266 counts, respectively.
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2.4 Quantification of SMI-32
In general healthy axons have phosphorylated neurofilaments supporting axonal transport
[31]. Damaged axons were examined using non-phosphorylated neurofilament positive IHC,
SMI-32. A representative SMI-32 EAE mouse optic nerve is shown in Fig. 2 – 6. Unlike DAPI,
SMI-32 produced a strong background signal. This required application of a background signal
removal process prior to threshold application. The background signal was removed using the
ImageJ plugin, rolling ball algorithm, http://rsbweb.nih.gov/ij/plugins/rolling-ball.html [32, 33].
Background signal subtraction was performed on 16-bit gray scale images. Briefly, the signalintensity profiles of whole 2D images were obtained in both horizontal and vertical directions,
Fig. 2 – 6 C. The process of obtaining intensity profile is like rolling a ball along each direction
and getting the intensity value. During this process, one should be aware of pixel size. If the
intensity profile is obtained per each pixel, or with a very small ball size, the obtained intensity
profile would be too noisy, preventing accurate background subtraction. To avoid this kind of
problem, appropriate pixel size (or ball size) should be applied. In this study, the pixel size of the
SMI-32-positive objective was determined manually from the digital microscope image. The
appropriate pixel size would vary depending on magnification of the digital image. In our
experience the appropriate pixel size has a radius equal to that of the positive object. Once the
intensity profile was obtained, the background was subtracted easily. Figure 2 – 6 shows the
intensity profile before and after background signal subtraction. The addressed protocol
successfully removed background signal but preserved IHC (SMI-32) positive objects. After
background subtraction, image was converted into 8-bit gray scale and then the SMI-32 positive
objects were selected using IsoData threshold and enumerated by ImageJ particle analysis
,http://rsbweb.nih.gov/ij/docs/menus/analyze.html, See also section of 2.3. Figure 2 – 7 shows
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the quantified SMI-32 without and with background subtraction. The strong background signal
without background subtraction caused huge amount of false positive SMI-32 counts. EAE mice
optic nerves having different severities of axonal damage could be differentiated using this
protocol of SMI-32 quantification, Fig. 2 – 8.
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Figure 2–6 Non-phosphorylated neurofilament stain (SMI-32) on mouse optic nerve and one
dimensional intensity profile. The SMI-32 stain on mouse optic nerve is shown in A (raw image)
and B (image with background intensity subtraction), 20x magnification. The panel A and B are
in same intensity scale. The panel C shows intensity profile without () and with () background
signal subtraction using rolling ball method. The background signal intensity is reduced by a
factor of 500 - 600.
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Figure 2–7 Quantification of SMI-32 positive axons using iterative selection threshold (IsoData)
without (panel A - C) and with (panel D - F) background signal subtraction (rolling ball
algorithm). The panel A - F are from the same raw image. Without background signal removal
(A) whole optic nerve is selected as SMI-32 positive objects using iterative selection threshold
(panel B and C). With background signal suppression (panel D) only SMI-32 true positive axons
are selected as objects (panel E and F).
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Figure 2–8 Panel A, B, and C are the representative 20x SMI-32 raw images of mice optic
nerves with non-injured, mild injury, and severe injury, respectively. The green line in each
panel is the border of optic nerves. After background signal suppression, the SMI-32 subtracted
maps are shown in panel D, E, and F. The quantified numbers of mice optic nerves within the
green lines with the three injury degree are 1, 96, and 226, respectively.
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2.5 Quantification of MBP
Myelin integrity was examined using myelin basic protein (MBP) IHC. Myelin wraps
around axons tightly. Consequently, the MBP positive stain has a small donut-ring shape in the
plane orthogonal to the long axis of the optic nerve, Fig. 2 – 9, and requires higher magnification
than DAPI or SMI-32. All histology maps including IHC maps would have significant amounts
of background signal intensity especially in high magnification, which could be interpreted as
false positives in intensity-based quantification analyses. Thus similar to SMI-32 stained images,
background signal was subtracted using the protocol described in Section 2.4. However, the
background signal subtraction on MBP stained micrographs still exhibit a noisy background, Fig.
2 – 9 E and F. In addition, the digitally captured histology maps would produce targets having
blurred edges even though high magnification would be used. The blurred edge would prevent
accurate target counting. Thus, the edge should be enhanced for accurate quantitative analysis.
Herein, we employed a bilateral filter, or so called conditional mean filter, which is based on a
Gaussian distribution, to preserve edges with noise reduced smoothing [34-36]. After
background signal subtraction on 16-bit gray scale, images were converted into 8-bit gray scale.
For noise reduction, a low-spatial-frequency = pass filter was employed with a pass-band
determined by the spatial radius of the object under investigation. Again, the appropriate spatial
radius would vary depending on magnification and target object dimensions. To enhance edges,
signal-intensity-range-based-filtering was applied. In this study, mean intensity of the whole
captured digital IHC image with background signal subtraction was used. Note that bilateral
filtering must be performed on 8-bit gray scale image after background signal subtraction on 16bit gray scale image. The effect of bilateral filtering for suppression of background noise on
MBP stain is well shown in Fig. 2 – 9 H and I. Once the bilateral filtering was done, the IsoData
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threshold was performed on MBP stain, Fig. 2 – 10. However, unlike DAPI and SMI-32, the
IsoData threshold missed many MBP positive regions, Fig. 2 – 10 D and F. So, an alternative
threshold method was needed. To determine an appropriate threshold for MBP positive objects,
the intensity histogram of the MBP stained image with background signal subtraction, image
conversion, and bilateral filtering was examined Fig. 2 – 11 B. The histogram then was analyzed
using a mono-exponential decay and exponential time constant, or exponential time constant of
intensity, was obtained and employed as threshold to determine MBP positive object. This
approach detected MBP positive regions accurately, which the IsoData threshold missed, Fig. 2 –
11 C and D. Using this optimized protocol, the EAE mice optic nerve having inflammation
induced myelin damage could be quantitatively analyzed, Fig. 2 – 12.
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Figure 2–9 Myelin basic protein (MBP) stained mouse optic nerve. The MBP stain on optic
nerve is shown at 60x magnification (panel A, D, and G). The panel C, F, and I are insets of
panel A, D, and G, respectively. The panel A and C are raw images. The panel D and F are
image with background subtraction (rolling ball algorithm). The panel G and I are images with
background subtraction and noise reduction by means of the rolling ball algorithm and bilateral
filter, respectively. The panel B, E, and H are one dimensional intensity profile of the region
indicated as straight line in panel A, D, and G, respectively. The positions of the onedimensional profiles are the same for all images. The raw MBP stain image shows non trivial
background signal (panel A – C). The background signal is suppressed effectively using the
same method as in Fig. 2-6 (panel D – F), yet leaves noise. The noise is reduced significantly via
bilateral filtering (panel G – I).
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Figure 2–10 Quantification of MBP using an iterative-selection threshold. The panel B – F are
insets of the panel A. The panel A and B are raw MBP-stained images. Panel C and E are images
with background subtraction (rolling ball algorithm). Panel D and F show the effects of both
background subtraction (rolling ball algorithm) and noise reduction using bilateral filtering. The
MBP positive objects are determined using iterative selection threshold (IsoData) methods,
similar to those used for DAPI and SMI-32 quantification (panel E and F). With background
subtraction only, the noise is determined by MBP-positive objects, panel E. The noise-induced
overestimation of MBP positive objects is not seen after bilateral filtering, panel F. However
there are multiple MBP-positive objects missed with iterative selection threshold, indicated by
arrow in D.
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Figure 2–11 Determination of MBP positive objects using intensity-histogram thresholding.
Panel A shows MBP staining with background subtraction and noise reduction. The intensity
histogram (Panel B) of the resulting image in panel A shows a clear mono-exponential decay.
The mono-exponential analysis of the intensity histogram produces an exponential time constant
of intensity which is used as threshold (C). Panel C shows MBP-positive objects determined
using exponential time constant of intensity as a threshold value, whereas panel D indicates
MBP-positive objects based on an iterative-selection threshold (IsoData). The yellow arrow in
Panel C indicates the location of a MBP-positive object detected using the mono-exponential
analysis that is missed when the iterative-selection threshold is used.
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Figure 2–12 Representative 60x MBP stain of mice optic nerves and quantified maps. MBPpositive myelin is shown for control (A – C) and injury (D – F) mouse optic nerves. The panel A
and D are raw images viewed at 60x. Panel B and E show the same images after applying the
threshold. Panel C and F are final binary maps of MBP-positive objects. The 60x magnification
has total 0.017 mm2 field of view. In the control image, myelin area was determined to account
for 0.0095 mm2 (C, 56% of total image area), whereas it is reduced to 0.0075 mm2 (F, 44% of
total image area) in the control specimen.
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2.6 Quantification of SMI-31
The total number of healthy axons determines the functional status of white-matter
pathways. In this study, the numbers of healthy axons was measured using the phosphorylated
neurofilament positive IHC stain, SMI-31. The axially sectioned axon would have small dot
shape and be separated from neighboring axons due to the presence of myelin sheath. However,
since IHC is based on fluorescence, two or more IHC positive targets can appear merged as one
big bundle, which may falsely reduce quantified counts. Thus, accurate and objective
segmentation should be done prior to quantification analysis for SMI-31. As one may see, SMI31 quantification requires all image-processing protocols addressed above and more. First, the
digitally captured SMI-31 gray scale 16-bit image underwent background signal subtraction,
image conversion from 16 to 8-bit gray scale, and bilateral filtering. And, yet the IsoData
threshold still couldn’t detect all SMI-31 positive axons, Fig. 2 –13. The exponential time
constant of intensity produced by intensity histogram analysis using exponential decay also
failed to accurately detect SMI-31 positive axons. This was mainly due to the vague border
between neighboring axons. To enhance the border between neighboring axons, a watershed
method was employed. The watershed segmentation is based on local maximum [37-40].
Briefly, two local maximum intensity pixels would be selected and then the pixel having lowest
intensity between two local maximum pixels would be selected as border. This process was
repeated until all border points were connected. The Fig. 2 – 14 shows the connected border
points successfully separating neighboring axons. However, this might produce false positive
axons (e.g., indicated with arrow in Fig. 2 – 14 b). False positive axons can be removed using
exponential analysis of the intensity histogram. Once image went through watershed
segmentation, the segmenting line was assigned zero intensity. Then the whole image intensity
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was analyzed using exponential analysis producing an exponential time constant of intensity.
The obtained exponential time constant of intensity value was employed to determine
thresholding for SMI-31 positive axons, Fig. 2 -15. This approach showed potential to enumerate
axons accurately and also remove false positive void areas, Fig. 2 –15 C and D. With these
image-processing steps, SMI-31 counts in specimens from mice having severe axonal loss could
be quantitatively analyzed, Fig. 2 – 16.
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Figure 2–13 Phosphorylated neurofilament (SMI-31) staining of mouse optic nerve and one
dimensional intensity profile. SMI-31 stain on mouse optic nerve is shown in 60x magnification
(A). Panel B – D are of an inset from A. Panel A and B are raw images. Panel C has background
subtraction (see Fig. 2 – 6) and noise reduction (see Fig. 2 – 9). Panel D is the result of iterative
selection threshold (IsoData). The brightness of d is increased to show axons that are both
selected and non-selected axons with this threshold. There are many SMI-31 positive objects
missed with the iterative-selection threshold (IsoData) (D).
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Figure 2–14 Watershed segmentation. A SMI-31-stained micrograph with background
subtraction and noise reduction is shown in Panel A. Panel B has watershed segmentation lines
separating adjacent SMI-31 positive objects. The brightness of panel B is enhanced to show both
SMI-31 positive objects and the segmentation lines. The watershed segments adjacent SMI-31
positive axons precisely yet there are segmentation lines in void area indicated by the arrow.
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Figure 2–15 Determination of threshold from a watershed map for quantification of SMI-31
positive axons. Panel A shows an SMI-31-positive image with background subtraction, noise
reduction, and watershed segmentation. The red segmentation lines are assigned zero intensity.
The intensity histogram of watershed segmentation map is shown in panel B. A monoexponential intensity decay is observed. Thus, exponential time constant of intensity is obtained
from mono-exponential analysis. The observed exponential time constant of intensity is used as a
threshold to determine SMI-31 positive objects (panel C). This threshold method detects SMI-31
positive objects precisely removing false positive void region indicated by the yellow arrow.
However, exponential time constant of intensity threshold produces very small objects as SMI31 positive objects. These small false positive objects are removed by selecting reasonable
particle sizes in particle analysis (panel D).
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Figure 2–16 Representative SMI-31 staining of mice optic nerves and quantified maps.
Phosphorylated neurofilament positive stain (SMI-31) of mouse optic nerves are shown for
control (panel A – C) and EAE specimens (panel D – F). Panel A and D are raw SMI-31 stain
images. Panel B and E are maps with threshold (see Fig. 2 – 15). Panel C and F are final binary
maps for SMI-31 positive axons wherein control counts were 6.1 × 105/mm2 and injury has 5.1 ×
105/mm2.
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2.7 Conclusion
In conclusion, an objective quantification of IHC staining can be achieved using the
aforementioned protocols. These protocols are highly reproducible and showed excellent
sensitivity to the specified IHC labeled cells. Therefore, the establishment of IHC quantification
protocols employed in our study provide for detailed and precise histologic validation of the in
vivo diffusion MR findings.
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Chapter 3
Quantifying white matter tract diffusion parameters in the presence of
increased extra-fiber cellularity and vasogenic edema
This chapter represents a manuscript initially submitted on June 26th, 2013 to NeuroImage and
currently under review. (Chia-Wen Chiang, Yong Wang, Peng Sun, Tsen-Hsuan Lin, Kathryn
Trinkaus, Anne H. Cross, and Sheng-Kwei Song)

Abstract
The effect of extra-fiber structural and pathological components confounding diffusion tensor
imaging (DTI) computation was quantitatively investigated using data generated by both MonteCarlo simulations and realistic tissue phantoms. Increased extent of vasogenic edema, by
addition of various amount of gel to fixed normal trigeminal nerves or by increasing nonrestricted isotropic diffusion tensor component in Monte-Carlo simulations, significantly
decreased fractional anisotropy (FA), increased radial diffusivity, while less significantly
increased axial diffusivity derived by DTI. Increased cellularity, mimicked by graded increase of
restricted isotropic diffusion tensor component in Monte-Carlo simulations, significantly
decreased FA and axial diffusivity with limited impact of radial diffusivity derived by DTI. The
recently developed novel diffusion basis spectrum imaging (DBSI) was also applied to detect
and quantify the increased cellularity and vsaogenic edema. Results showed that increased
cellularity or vasogenic edema did not change the DBSI derived fiber FA, axial or radial
diffusivity. The extent of extra-fiber cellularity and edema estimated by DBSI correlated with
experimentally added gel and true values of Monte-Carlo simulations. We also examined the
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feasibility of applying 25-direction diffusion encoding scheme for DBSI analysis on coherent
white matter tracts. Results suggested that the 25-direction diffusion scheme provided accurate
DBSI estimation of both fiber diffusion parameters and extra-fiber cellularity/edema extent. An
in

vivo

25-direction

DBSI

analysis

was

performed

on

experimental

autoimmune

encephalomyelitis (EAE, an animal model of human multiple sclerosis) optic nerve as an
example to demonstrate the validity of derived DBSI parameters with post-imaging
immunohistochemistry verification.
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3.1 Introduction
Diffusion tensor imaging (DTI) successfully detects axon and myelin injury through
decreased axial diffusivity (λ║, parallel to white matter tract) and increased radial diffusivity (λ,
perpendicular to white matter tract) in animal models of central nervous system (CNS) diseases
and injuries [1-4]. Although decreased fractional anisotropic (FA) has been demonstrated to
reflect myelin damage in multiple sclerosis (MS) [5], it is not a marker specific to myelin
damage since other pathological components may also contribute to diffusion anisotropy change
[6, 7]. For example, inflammation associated vasogenic edema has been recognized to increase
apparent diffusion coefficient underestimating the diffusion anisotropy of fiber tracts [8, 9].
Increased cellularity has been demonstrated to decrease apparent diffusion coefficient [10].
However, its impact on diffusion anisotropy remains unclear. An in vivo experiment of white
matter inflammation in rats has suggested the association of DTI derived apparent diffusion
coefficients (ADC) with the evolution of pathology [11]. It is without a doubt that various
pathological components impact DTI derived metrics.
DTI assumes that diffusion of water molecules in the CNS white matter follows monoexponential diffusion signal decay (typically at b-value < 1000 s/mm2) as a single anisotropic
tensor. Thus, diffusion anisotropy of white matter tracts in the presence of multiple structural and
pathological compartments poses significant challenges in DTI analysis of white matter tracts
since non-Gaussian models or multiple diffusion tensors are needed to correctly reflect the tissue
and pathological complexity. Various diffusion techniques have been proposed to overcome the
limitation of DTI by non-Gaussian modeling of both parametric (model-based) or nonparametric (model-free) approaches. For instance, diffusion spectrum imaging (DSI) resolves
crossing or branching fibers by direct evaluation of diffusion displacement probability density
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function which is the inverse Fourier transform of the diffusion weighted signals, but typically
requires a large number of measurements [12]; diffusion kurtosis imaging (DKI) quantifies the
non-Gaussian diffusion by estimating apparent diffusion kurtosis of diffusion displacement
probability distribution [13]; generalized diffusion tensor imaging (gDTI) models the white
matter tract via higher order tensors [14]; composite hindered and restricted model of diffusion (CHARMED) evaluates an extra-cellular compartment (assigned to hindered diffusion resulting
from extra-axonal diffusion weighted signal) and intra-cellular compartments (assigned to
restricted diffusion in a cylinder with zero radius representing individual intra-axonal space)
employing a comprehensive diffusion weighting scheme [15]. Recently, Scherrer et al. proposed
multiple fascicle models (MFM) to model an isotropic compartment (assigned to free water
diffusion) and multiple anisotropic compartments (assigned to single fascicle) using a cube and
sphere (CUSP) acquisition scheme [16]. Zhang et al. proposed neurite orientation dispersion and
density imaging (NODDI) to model tissue components. Using high-angular-resolution diffusion
imaging (HARDI) acquisition scheme, NODDI assesses intra-cellular (assigned to space within
neurites), extra-cellular (assigned to space around the neurites but occupied by glial cells), and
CSF compartments for deriving neurite density and orientation dispersion [17]. Although these
approaches resolve possible fiber orientations and free water diffusion contaminations
confounding DTI in the CNS, the restricted water diffusion outside fiber tracts affecting DTI
measurements has not been dealt with.
The recently-developed diffusion basis spectrum imaging (DBSI) approach models white
matter diffusion as the linear combination of multiple discrete anisotropic diffusion tensors
describing axonal tracts and a spectrum of isotropic diffusion tensors describing restricted
(reflecting cells), non-restricted (reflecting extra-axonal and extracellular space) diffusion
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components outside of axonal tracts [18]. Employing a 99-direction diffusion-encoding scheme,
DBSI has shown promise to accurately detect and quantify crossing fibers, axonal injury,
demyelination, and inflammation-associated cell infiltration and edema in both ex vivo phantom
and in vivo mouse brain. Although the effect of increased cell infiltration and edema on DTIderived indices has been demonstrated preliminarily using cuprizone treated mouse model and
mouse trigeminal nerve phantoms (Wang, 2011), a more comprehensive study was needed to
investigate the effect of increased cellularity and vasogenic edema associated with inflammation.
In this study, diffusion weighted signals derived from Monte-Carlo simulations and
experimentally acquired from realistic tissue phantoms of fixed mouse trigeminal nerve and 2%
agar gel were employed to demonstrate how various inflammatory components change DTI
indices. The accuracy of DBSI to resolve the complication of inflammation was also examined.
Although the original 99-direction diffusion encoding scheme is readily implemented in
clinical scanners, it poses significant challenges in the animal scanners to obtain DBSI data from
mouse CNS. To image the coherent white matter tracts without fiber crossing, such as optic
nerve and spinal cord, a simplified DBSI with NAniso = 1 would be sufficient and require less
diffusion encoding directions. A reduced scanning time can be achieved by significantly
reducing the number of diffusion weighted images. Thus, we adopted a 25-direction diffusion
encoding scheme [19] on both Monte-Carlo simulations and realistic tissue phantoms.
Comparisons between 25- and 99-direction DBSI results on both simulated and experimental
data were conducted to examine the accuracy of DBSI analysis using the 25-direction diffusion
encoding scheme. To further demonstrate the feasibility of the 25-direction scheme for DBSI
analysis, in vivo diffusion MRI was performed on an EAE-affected mouse at the onset of optic
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neuritis. The in vivo diffusion MRI data were analyzed using DBSI and verified by post-imaging
immunohistochemistry.

3.2 Materials and Methods
3.2.1 Diffusion-encoding schemes
Both 99- [18] and 25-direction [19] diffusion-encoding schemes were employed for
DBSI analysis in this study. The 99 diffusion-encoding directions were selected as prescribed in
diffusion spectrum imaging (DSI) where the position vectors are the entire grid points (qx, qy, qz)
over the 3-D q-space under the relationship that (qx2+qy2 +qz2) ≤ r2, where r = 3 for DBSI [20, 12,
18]. The icosahedral 25-direction sampling scheme was as prescribed by Batchelor et al. with the
addition of one extra non-diffusion (b = 0) weighted image. See Appendix A and B for a detail of
99- and 25-direction diffusion-encoding schemes, respectively.

3.2.2 Fixed trigeminal nerve phantom
Trigeminal nerves from adult female normal C57BL/6 mice (The Jackson Laboratory,
Bar Harbor, ME) were dissected after fixation and kept in 0.01 M phosphate buffered saline
(PBS) solution. Twenty trigeminal nerves were employed to generate phantoms of a single
trigeminal nerve only (n = 7) and a single nerve juxtaposed with different amount of 2% aqueous
agar gel to mimic vasogenic edema (n = 13). All phantoms were prepared on a slide and covered
with plastic wrap immediately before measurements to avoid dehydration. Diffusion-weighted
data were collected utilizing a diffusion-weighted spin-echo spectroscopy sequence with 99- and
25-direction schemes at a single setting with the following acquisition parameters: TR 2 sec, TE
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32 ms, Δ 16 ms, δ 8 ms, 1 average, and maximum b-value 3200 s/mm2 for ex vivo. Total
acquisition time was 4 min 15 sec.

3.2.3 Monte-Carlo simulation
Monte-Carlo simulations were performed to evaluate the effect of vasogenic edema and
cellularity on DTI and DBSI indices in the aforementioned realistic tissue phantoms. The
simulation was performed by allowing water molecules (2.5 × 105, randomly distributed) to
undergo random walk within a 90-µm diameter sphere (light blue, Fig. 3 - 1 A) at 20 ºC. Thus,
diffusivity for free water was set to be 2.02 µm2/ms. The time-step for simulated random walk
was 0.2 ms. The computer simulation model of the trigeminal nerve phantom were composed
with (1) a coherent axon fiber bundle modeled by uniformly oriented, and tightly packed
cylindrical tubes (green cylinders in Fig. 3 – 1 A) with diameter of 2 µm; (2) cellular
components modeled as isotropic spheres (blue in Fig. 3 – 1 A) with a diameter of 6 µm
randomly placed surrounding the axonal fiber bundle; (3) extra-axonal and extracellular space
occupied by water molecules distributed outside of axonal bundle and cellular components (Fig.
3 - 1 A). The size of axonal cylinder and cells was adapted according to literature reports [21,
22]. The imaging voxel (50 × 50 × 50 µm3, pink cube in Fig 1A) was placed in the center of the
sphere defined for random walk (light blue outer sphere in Fig. 3 - 1 A). At the boundary of axon
and cell components, the water spin reflected elastically [14]. During the simulation, water spins
were allowed to walk in or out of the imaging voxel without constrains to reflect the real
physical condition [14]. The boundaries of the axon and cell components were assumed to be
impermeable. The random walk trajectory of each water spin was recorded and saved during the
simulation.
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Based on previous mouse trigeminal nerve phantom study [18], baseline trigeminal nerve
model (model # 1, Fig. 3 - 1 B), the simulation of nerve only phantom, consisted of 12% cells
(133 spheres), 68% axonal fibers (529 cylinders), and 20% extra-axonal/extracellular space. The
tissue phantom of single nerve plus gel was simulated by increasing the size of imaging voxel of
baseline nerve model, thereby increasing the extra-axonal/extracellular space (model # 2-11, Fig.
3 - 1 B), to mimic vasogenic edema. For model # 2-11, the cellularity ranged from 7% to 15%,
the axonal fiber fraction ranged from 15% to 57%, and the extra-axonal/extracellular space
ranged from 27% to 78% (Fig. 3 – 1 B). Although it is very challenging to control the amount of
cellularity in the experimental trigeminal nerve phantom, varied cellularity was readily simulated
by simply increasing the number of spheres (cells) inside the imaging voxel. Models with
different amount of cellularity content (model # 12-21) were generated by increasing number of
spheres into the imaging voxel. For simulations of varied cellularity (model # 12-21), the
cellularity ranged from 14% to 80%, the axon fiber fraction ranged from 12% to 63%, and the
extra-axonal/extracellular space ranged from 8% to 22%.
A simple spin echo sequence with diffusion gradients was implemented to simulate the
diffusion weighted MRI signals from the imaging voxel. The simulated phase of each water spin
at the echo time (TE) was calculated based on the random walk trajectory [14]. The overall
measured diffusion MRI signal was simulated as the summation of signals contributed from all
water spins, ending within the voxel of imaging at the time of TE. The effect of T1 and T2 decay
for all spin trajectories were neglected [14]. Both 99- and 25-direction schemes were employed
to acquire the diffusion weighted signals. Other key MRI acquisitions parameters included TE 32
ms, Δ 16 ms, δ 8 ms, maximum b-value 3200 s/mm2 were kept the same intentionally with the
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fixed trigeminal nerve phantom experiment above. Rician noise was added to simulated diffusion
MRI signals to mimic the typical achievable signal-to-noise ratio (SNR) = 40 in our hands.

3.2.4 In vivo diffusion MRI of acute optic neuritis
A female 8-week-old C57BL/6 mouse (The Jackson Laboratory, Bar Harbor, ME, USA)
was

immunized using 50 μg myelin oligodendrocyte glycoprotein peptide (MOG35-55)

emulsified in incomplete Freund’s adjuvant with 50 μg Mycobacterium tuberculosis. One agematched sham female mouse received only incomplete Freund’s adjuvant in the absence of
MOG35-55 and Mycobacterium tuberculosis. For EAE-immunized mouse, the adjuvant pertussis
toxin (300 ng; PTX, List Laboratories, Campbell, CA) was injected intravenously on the day of
immunization and two days later. Transverse view of mouse optic nerve was imaged when visual
impairment was first detected at the onset of acute EAE optic neuritis [23].
In vivo diffusion MRI experiments were performed on a 4.7-T Agilent DirectDrive™
small-animal MRI system (Agilent Technologies, Santa Clara, CA) equipped with
Magnex/Agilent HD imaging gradient coil (Magnex/Agilent, Oxford, UK) with pulse gradient
strength up to 58 G/cm and a gradient rise time ≤ 295 µs. After anesthetizing using 1%
isoflurane/oxygen, mice were placed in a custom-made head holder. The rate of respiration and
rectal temperature, at 37 ºC, was monitored and controlled by a small animal physiological
monitoring and control unit (SAII Inc., NY). An actively-decoupled volume (transmit) /surface
(receive) coil pair was used for MR excitation and signal reception. All image slices were
acquired based on previously reported procedures [24]. A final-targeted slice showing a
transverse view of mouse brain with two optic nerves, as nearly as orthogonal to image slice as
possible, resulted (Fig. 3 – 2 A). A multi-echo spin-echo diffusion-weighted sequence [25] and a
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25-direction diffusion-encoding scheme combined with one b = 0 were employed and MR
acquisition parameters were TR 1.5 sec, TE 37 ms, Δ 18 ms, δ 6 ms, max. b-value 2200 s/mm2,
slice thickness 0.8 mm, in-plane resolution 117 µm × 117 µm (before zero-filled). The total
acquisition was approximately 2 hour, 20 minutes.

3.2.5 Immunohistochemistry
Mice were perfusion fixed with 0.01 M phosphate-buffered saline (PBS) followed by 4%
paraformaldehyde in 0.01 M PBS immediately after imaging. Brains were excised and fixed for
24 h, and then transferred to 0.01 M PBS for storage at 4 ºC until histological analysis. Fixed
optic nerves were embedded in 2% agar blocks [26] before being embedded in paraffin. Five-µm
thick transverse slices were sectioned, deparaffinized, rehydrated, and blocked using a 1:1
mixture of 10% normal goat serum and 2% bovine serum albumin in PBS for 20 min at room
temperature to prevent nonspecific binding of goat secondary antibody. Sections were incubated
in monoclonal anti-phosphorylated neurofilament primary antibody (SMI-31; 1:1000, Covance,
US) to stain non-injured axons, or in rabbit anti-myelin basic protein (MBP) primary antibody
(1:1000, Sigma Inc., MO) to stain myelin sheath at 4 ºC overnight. After several rinses,
secondary goat anti-mouse IgG and goat anti-rabbit IgG conjugated Alexa 488 (1:800,
Invitrogen) were applied respectively to visualize immunoreactivity of materials at room
temperature for 1 h. After washing, slides were covered using Vectashield Mounting Medium
with 4´,6-diamidino-2-phenylindole (DAPI) (Vector Laboratory, Inc., Burlingame, CA).
Histological images were acquired at 20x and 60x (water objective) magnifications on Nikon
Eclipse 80i fluorescence microscope using MetaMorph software (Universal Imaging
Corporation, Sunnyvale, CA).
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3.2.6 Data analysis
Experimental and simulated data using 99- and 25-direction diffusion encoding schemes
were examined by DBSI multi-tensor model analysis package developed in-house with Matlab®
(MathWorks) [18] and conventional DTI single-tensor model analysis. Briefly, Eq. [1] was first
solved by fitting total number k diffusion signals using a linear combination of diffusion basis
sets consisting of cylindrically symmetric diffusion tensors with the freedom to vary λ║ and λ to
estimate the number of anisotropic diffusion tensor components (NAniso) and the associated
principal directions. After NAniso was computed, isotropic components were further analyzed
using nonnegative least-squares (NNLS) technique. For coherent white matter tract in this study,
NAniso = 1.The global nonlinear optimization was conducted employing direct pattern search to
solve Eq. [1]. Sk is the kth measured diffusion weighted signals (k = 1, 2, …, 99 (or 25) in this
study). fi and f (D) are signal intensity fractions of ith anisotropic diffusion components and a
spectrum of isotropic diffusion components from a to b (typically from 0 to 5) diffusivity,
respectively.
1, 2, 3, …

∥

1

3.2.7 Statistical analysis
All data were expressed as mean ± standard deviation. The comparison between DTI and
DBSI derived diffusion parameters was performed on data obtained from trigeminal nerve
phantoms and from Monte-Carlo simulations using linear repeated measures regression models.
Two one-sided t-tests (TOST) at a 0.05 significance level were performed to test equivalence of
99- and 25-direction DBSI derived λ║, λ, and FA, as well as the diffusion fractions of different
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components. The tests were repeated for data from models with a changing proportion of extraaxonal/extracellular space and for those with a changing proportion of cells. One test compared
the mean difference to an upper equivalence boundary and the other to a lower equivalence
boundary, defined as ± 2 × standard deviations. All statistical analyses were performed using
SAS V9.3 (SAS Inc., Cary, NC).

3.3 Results
3.3.1 Effect of vasogenic edema on DTI derived parameters
In trigeminal nerve only phantoms, DTI derived λ║ = 0.77 ± 0.05 µm2/ms, λ = 0.18 ±
0.02 µm2/ms, and FA = 0.72 ± 0.04 were compared with those derived using DBSI where λ║ =
1.09 ± 0.06 µm2/ms, λ = 0.15 ± 0.02 µm2/ms, FA = 0.84 ± 0.02 (n = 7, mean ± standard
deviation). With the addition of 2% agar gel, DTI derived λ or FA was significantly affected
while DBSI derived parameters remained unchanged (Fig. 3 – 2 A). A comparable observation
was seen in Monte-Carlo simulation data where DTI derived FA decreased while λ║, λ
increased with increasing vasogenic edema (i.e., extra-axonal/extracellular space, non-restricted
isotropic diffusion component; Fig. 3 - 2 B) with relatively stable DBSI derived FA, λ║, and λ.

3.3.2 Effect of increased cellularity on DTI derived parameters
In the fixed trigeminal nerves (n = 7), DBSI estimated axonal fiber fraction to be 67 ±
3%, cellularity to be 14 ± 2%, and extra-axonal/extracellular space to be 20 ± 3% of the total
signal

intensity,

consistent

with

our

previously

published

results

supported

by

immunohistochemistry [18]. Since cellularity is difficult to change experimentally, Monte-Carlo
simulation was performed with various extents of extra-fiber cells (i.e., spheres, restricted
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isotropic diffusion component). Diffusion parameters derived by DTI were significantly affected
with increasing cellularity, i.e., DTI derived λ║, and FA significantly decreased with increasing
cellularity while DBSI derived parameters were largely unaffected (Fig. 3). DTI derived λ was
minimally affected in contrast to the more profound changes seen in λ║. No correlation was
shown in FA, λ║, and λ between DTI and DBSI.

3.3.3 Reducing the number of diffusion encoding direction for trigeminal nerves
There was no discernible difference between 25- vs. 99-direction diffusion encoding
scheme in DBSI derived diffusion parameters on data generated using Monte-Carlo simulation
(Fig. 3 – 2 B, 3 – 3 and 3 – 4). Similarly consistent findings were also seen in the experimental
data using trigeminal nerves combined with varied amounts of 2% agar gel (Fig. 3 - 2 A). The
accuracy of diffusion fractions from both 99- and 25-direction DBSI analysis of data from
Monte-Carlo simulations (n = 21) were evaluated. DBSI derived non-restricted and restricted
isotropic diffusion fractions using 99- and 25-direction diffusion schemes (Fig. 3 – 4 A and B)
were not different from the simulated true values. DBSI derived restricted and non-restricted
isotropic diffusion fractions using 25-direction compared to 99-direction were statistically not
different by equivalence tests.

3.3.4 An in vivo example of EAE optic neuritis
Diffusion MRI using the 25-direction scheme was performed on optic nerves from one
sham mouse and one with optic neuritis due to EAE. Both DBSI and DTI analyses exhibited
decreased λ║ (DBSI λ║ = 1.38 vs. 2.10 µm2/ms; DTI λ║ = 0.72 vs. 1.92 µm2/ms for EAE vs.
sham) and increased λ (DBSI λ = 0.13 vs. 0.11 µm2/ms; DTI λ = 0.20 vs. 0.10 µm2/ms for
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EAE vs. sham) in the EAE-affected optic nerve comparing with those of the sham. In addition to
the conventional diffusivities, DBSI derived restricted isotropic diffusion fraction (i.e., the
putative cellularity) = 0.25 vs. 0.03, non-restricted isotropic diffusion fraction (i.e., the putative
vasogenic edema) = 0.22 vs. 0.02 significantly increased in the optic neuritis-affected nerve
comparing with the sham nerve, reflecting the inflammation.
A close examination of the DBSI parameter maps of sham (Fig. 3 – 5 A, B, and C) and
EAE-affected (Fig. 3 – 5 D, E, and F) mice suggested the presence of inflammatory cell
infiltration evidenced by the increased restricted isotropic diffusion fraction, axonal injury
supported by the decreased λ║, and demyelination indicated by the increased λ in the EAEaffected optic nerve. Apparent heterogeneity of cell infiltration was also seen on the crosssection image of the optic nerve, consistent with a heterogeneous increase in DAPI-positive cell
nuclei staining (Fig. 3 – 5 D and D’). Qualitatively, axonal injury (decreased λ║) and
demyelination (increased λ) occurred within the regions where increased cellularity (increased
restricted isotropic diffusion fraction) was present (Fig. 3 – 5 D, E, and F). However, the
presence of increased cellularity does not necessarily correspond to axonal injury or
demyelination. These in vivo DBSI findings were supported by immunohistochemical staining.

3.4 Discussion
This study investigated the effect of increased cellularity and vasogenic edema,
commonly seen in CNS injuries, on the DTI derived diffusion parameters of white matter tracts.
Specifically, increased cellularity as evidenced by increased isotropic, restricted diffusion,
decreased the DTI derived FA and λ║ while having a limited impact on λ. Increased vasogenic
edema, as evidenced by increased non-restricted isotropic diffusion, also decreased the DTI
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derived FA but increased λ with the extent of impact on λ║ depending on the ADC value of
edema relative to λ║ and λ of axon. These confounding effects were resolved and quantified by
the recently developed DBSI analysis [18], as demonstrated herein using data generated by both
Monte-Carlo simulation and realistic tissue phantoms. Our prior study used 99-direction
diffusion encoding [18]. A 25-direction diffusion encoding scheme [19] was assessed in this
study to demonstrate its adequacy for performing DBSI analysis on optic nerves from the mouse
at the onset of acute optic neuritis.
The partial volume effect of CSF, i.e., non-restricted (free) isotropic diffusion, on DTI
indices has long been recognized, and limits DTI capability in regions abutting CSF, such as
periventricular regions that are commonly affected by MS. The inclusion of the isotropic
component of free diffusion improved fiber diffusion measurements [27, 28]. However, such
modification is insufficient to deal with coexisting CNS inflammation (increased cellularity and
vasogenic edema) or tissue loss that may be seen in diseased tissues [29]. To properly model the
effect of CNS inflammation and tissue loss, allowing a more accurate evaluation of the diffusion
properties of white matter fiber tracts, multiple extra-fiber diffusion components (both restricted
and non-restricted isotropic diffusion components) must be identified and quantified. DBSI
considers a spectrum of isotropic diffusion components of a wide range of ADC to account for
the extra-fiber tissue and pathological components. The current results from fixed normal tissues
and gel phantoms, and our previous in vivo mouse brain data [18] suggest that the DBSI
approach allowed for an accurate estimation of white matter tract diffusion properties in the
presence of increased cellularity and vasogenic edema.
The close agreement between the experimental measurements of fixed trigeminal nerve
plus gel phantoms and the results from Monte-Carlo simulations using restricted and non82

restricted isotropic diffusion components to mimic cells and vasogenic edema supported our
approach of including a linear combination of isotropic diffusion spectra to account for the effect
of CNS inflammation and tissue loss. One advantage of using DBSI is its capability to resolve
crossing fibers while still quantitatively deriving fiber associated anisotropic diffusion tensors to
assess the axon and myelin integrity [18]. Previously, a 99-direction diffusion encoding scheme
was employed to acquire data for DBSI analysis that was able to resolve crossing fibers and
quantifying extra-fiber cellularity and edema [18]. In the case where crossing fibers are not of
concern such as when studying optic nerve, a reduced data acquisition scheme may be sufficient
for DBSI analysis. In the present study, the 25-direction diffusion scheme was assessed and
proved to be adequate and equivalent to the 99-direction scheme for DBSI analysis in coherent
white matter tracts to quantify the extent of cellularity and edema. Thus, DBSI analysis may
potentially be applied to existing diffusion weighted data acquired using 25- or other multipledirection encoding schemes with multiple b-values may be suitable for DBSI analysis without
reacquiring new data to examine the single coherent fiber tracts.
Similar to previous results on corpus callosum from cuprizone treated mice [18], in vivo
DBSI derived restricted isotropic diffusion fraction map of optic nerve from the EAE mouse
revealed a heterogeneous increase in amount of cellularity closely matching the pattern of DAPIpositive cell nuclei staining of the same nerve (Fig. 3 – 5 D and D’). This result is very
encouraging because it demonstrates that DBSI could potentially provide a novel noninvasive
index of inflammation in white matter to monitor in real time of cellular infiltration. In contrast,
various MR techniques have been used to assess inflammation of optic neuritis, but rarely
demonstrated the ability to image cellularity changes non-invasively. For example, gadoliniumenhanced T1W images reflect the leakage of blood-brain barrier [30-32] without information
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regarding the cellular infiltration. Iron-oxide particles have been used to allow in vivo
visualization of macrophages, but this method is insensitive to non-phagocytic cells involved in
inflammation [33]. An increased optic nerve area (swelling) has also been considered to reflect
the severity of inflammation in acute optic neuritis [34, 35]. Unfortunately, this method is highly
nonspecific, as a changed nerve cross-sectional size may reflect cell infiltration and/or edema
and is further confounded by any tissue loss that may be present [34]. In the present study,
axonal injury and myelin damage seen in the EAE-affected optic nerve co-localized with cell
infiltration while the region of increased cellularity did not always correspond to visible nerve
damage (Fig. 3 – 5 D - F). This is consistent with the pathogenesis of optic neuritis in EAE, i.e.,
nerve injury originates from the induced CNS inflammation but may not always occur with
inflammation, and when it does occur axon injury may extend well outside the region of
inflammation [36, 37].
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Figure 3–1 (A) A three-dimensional computer-synthesized trigeminal nerve model was
constructed for Monte-Carlo simulations. The coherently oriented axonal fiber bundle was
composed of tightly packed cylinders of 2-µm diameter (green cylinders), to be described by
anisotropic water diffusion components. Cells were represented by spheres of 6-µm diameter
(blue spheres) randomly placed surrounding the fiber bundle for simulating restricted isotropic
water diffusion in cells. Extra-axonal/extracellular space was represented as non-restricted
isotropic diffusion within an imaging voxel. Voxel of interest (50 × 50 × 50 µm3 pink cube) was
placed in the center of the simulation space for the random walk of water molecules (light blue
outer sphere of 90-µm diameter). (B) Baseline trigeminal nerve model (model # 1) consisted of
intra- and extra-axonal water diffusion closely associated with axonal fibers (anisotropic
diffusion; green bar), cells (restricted isotropic diffusion; blue bar) and extra-axonal/extracellular
space (non-restricted isotropic diffusion; pink bar). Similar to the fixed normal trigeminal nerve
phantoms with different amount of gel, by gradually increasing the size of imaging voxel, a set
of baseline trigeminal nerve model with varying fractions of non-restricted isotropic diffusion
(model # 2-11) was used to assess the impact of edema on DTI and DBSI measurements. By
increasing the number of spheres, i.e., restricted isotropic diffusion components (model # 12-21),
the impact of increased cellularity on DTI and DBSI was also assessed.
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Figure 3–2 The impact of vasogenic edema (or tissue loss) on DTI (open symbols) and DBSI
(filled symbols) measurements was mimicked experimentally by adding various amount of 2%
agar gel to the fixed normal trigeminal nerve (A) or by increasing the extent, i.e., by enlarging
the voxel size without changing the cell or axon bundle content, of non-restricted diffusion
component in the Monte-Carlo simulation (B). Experimentally (A), increased gel content
resulted in overestimating DTI derived λ║ and λ (comparing with the nerve only phantom)
while underestimated FA (open symbols). The DBSI derived diffusion parameters were not
affected by varying the content of the gel (filled symbols). On the data generated using MonteCarlo simulation (B), increasing non-restricted diffusion components also resulted in
overestimating DTI derived λ║ and λ while underestimated the FA (open symbols). The DBSI
derived diffusion parameters (filled symbols) were not affected by increasing non-restricted
diffusion component.
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Figure 3–3 Due to the difficulty in making reliable experimental phantoms with varying cell
contents, Monte-Carlo simulations with varying contents of the restricted diffusion components
were performed to mimic the inflammation associated cellularity increase. Increased content of
restricted diffusion component significantly underestimated the DTI derived λ║ and FA without
an impact on λ. None of the DBSI derived diffusion parameters was affected by the increased
restricted diffusion component.
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Figure 3–4 DBSI derived non-restricted (A) and restricted isotropic diffusion fraction (B) using
99- (circle) and 25-direction (triangle) diffusion encoding scheme was compared with the input
values used for Monte-Carlo simulations. Data obtained from both diffusion encoding schemes
fall on the line of identity (black dashed lines in A and B) suggesting that DBSI analysis can be
accurately performed using 25-direction encoding scheme in situations where fiber crossing is
not of concern.
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Figure 3–5 Representatives in vivo DBSI derived fraction of restricted isotropic diffusion
(cellularity), λ║, and λ maps of the optic nerves from the sham and EAE-affected mice were
obtained using the 25-direction diffusion encoding scheme. DBSI maps of restricted isotropic
diffusion fraction, λ║, and λ of sham (A, B, C) and EAE (D, E, F) mouse optic nerves were
compared to immunohistochemistry images of DAPI (blue), SMI-31 (green), MBP (red) from
sham (A’, B’, C’) and EAE (D’, E’, F’) optic nerves, corresponding to the selected area from
DBSI maps (B, C, E, F). Increased restricted diffusion fraction (0.25 vs. 0.03 for EAE vs. sham),
decreased DBSI derived λ║ (1.38 vs. 2.10 µm2/ms for EAE vs. sham), and slightly increased
DBSI derived λ (0.13 vs. 0.11 µm2/ms for EAE vs. sham) was seen in the optic nerve with optic
neuritis, correctly reflecting the optic nerve pathologies seen by immunohistochemistry. For
example, the heterogeneously increased cellularity in the EAE optic nerve cross-section map
detected by DBSI derived restricted isotropic diffusion fraction closely corresponded to the
heterogeneity of DAPI-positive cell nuclei staining intensity. Similarly, correspondence between
decreased λ║ and the decreased SMI-31 (representing loss of axons) and between increased λ
and the decreased MBP (representing demyelination) staining intensity was also seen. This
strong correspondence between in vivo DBSI and postmortem immunohistochemistry findings
supports that the 25-direction diffusion encoding scheme is adequate for assessing optic nerve
pathologies in EAE mice. Scale bars represent 100 µm (F and D’), 10 µm (F’).
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Appendix 3–A
99-direction DBSI diffusion-encoding scheme (Wang et al., 2011)
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Appendix 3–B
25-direction, icosahedral sampling scheme (Batchelor et al., 2003)

95

Chapter 4
Diffusion basis spectrum imaging detects and differentiates coexisting
inflammation, demyelination, and axonal injury in acute optic neuritis
This chapter represents the latest version of a manuscript that is targeted for submission to
NeuroImage. (Chia-Wen Chiang, Yong Wang, Tsen-Hsuan Lin, Kathryn Trinkaus, Anne H.
Cross, and Sheng-Kwei Song)

Abstract
Diffusion tensor imaging (DTI) measured directional diffusivities have been widely applied to
investigate central nervous system (CNS) white matter pathologies. However, CNS white matter
pathologies can be complex, and include combinations of demyelination, axon injury/loss,
inflammation and edema. The largely isotropic diffusion components of inflammation, namely
cellular inflammation and edema, and tissue loss may confound the interpretation of DTI derived
biomarkers that focus only on the anisotropic components of white matter pathologies. Thus, a
multiple-tensor based diffusion basis spectrum imaging (DBSI) has been proposed to resolve the
confounding effect of inflammation. In the present study, a comparison between the newly
developed DBSI and the conventional DTI was performed on the optic nerve of mice with optic
neuritis due to experimental autoimmune encephalomyelitis (EAE). Notably, optic neuritis is a
common early symptom of multiple sclerosis, for which EAE serves as a main model. Both DTI
and DBSI correlated well with visual function measured by visual acuity in EAE-affected mice.
However, DTI was unable to identify the underlying inflammation due to the associated increase
in cellularity and vasogenic edema in acute optic neuritis. The current study demonstrated the
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advantage of DBSI in specifically detecting and distinguishing inflammation, demyelination, and
axonal injury in optic neuritis due to EAE.
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4.1 Introduction
Optic neuritis (ON) is an early symptom in patients of multiple sclerosis (MS) [1, 2].
Accumulated axonal degeneration is now considered as the primary cause of permanent
disability in MS [3]. In MS, inflammatory demyelination and axon loss within the optic nerve
parallel that seen in the rest of central nervous system (CNS) white matter [3-5]. An imaging
method that would non-invasively show optic nerve pathology and that would correlate with
visual function due to ON could provide a window to better understand the underlying causes for
disease progression in MS. EAE provides a model system to investigate the interrelationship
between functional outcome, neuropathology, and imaging.
Previously, several clinical and neurophysiology methods have been used to
noninvasively detect functional deficits and structural changes in the visual pathway due to ON.
Decreased visual acuity (VA) indicates dysfunction of the visual pathway without specificity of
location or underlying pathology (Regan et al., 1977). An increased latency and a reduced
amplitude in visual evoked potential (VEP) is considered to reflect demyelination and axonal
damage in the optic nerve respectively [6, 7]. Retinal nerve fiber layer thinning and macular
volume reduction detected by optical coherence tomography (OCT) reflect axon and ganglion
cell (neuron) loss correlating with VEP amplitude and vision tests after ON [8-11]. Recently, by
adopting a novel retinal segmentation analysis, OCT has detected the retinal neuronal layer, i.e.,
ganglion cell layer plus inner plexiform layer and inner nuclear layer plus outer plexiform layer,
where reduction in thickness has been associated with disease progression in MS [5, 12-14].
Magnetic resonance imaging (MRI) directly assesses optic nerve integrity and can
localize and quantify pathological foci. For example, an increased optic nerve cross-sectional
area (swelling) has been considered to reflect the severity of inflammation (cell infiltration and
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edema) associated with visual impairment in acute ON [15, 16]. Gadolinium (Gd)-enhanced T1weighted (T1W) lesions in optic nerve, indicating blood-brain barrier dysfunction as a result of
inflammation, correlated with visual recovery following acute ON [17, 18].
Decreased axial diffusivity (λ║, water diffusion parallel to the white matter fibers)
detected by diffusion tensor imaging (DTI) correlated with slowed visual recovery [19]. An
increased radial (λ, water diffusion perpendicular to the white matter fibers) and mean
diffusivity (MD), and a decreased fractional anisotropy (FA) derived by DTI correlated with
long-term visual recovery [20]. Despite the promising predictive results using DTI in acute and
chronic ON in humans, DTI cannot reflect the underlying pathologies or cerebrospinal fluid
(CSF) contamination, largely reflected as isotropic diffusion, of the voxel being examined. Thus,
a new method termed diffusion basis spectrum imaging (DBSI) has been developed to detect and
quantify increased cellularity and vasogenic edema associated with inflammation, while more
accurately reflecting axonal injury and demyelination [21]. Moreover, DBSI can also detect CSF
contamination and resolve crossing fibers within an imaging voxel [21].
Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model of
human MS [22]. C57BL/6 mice with EAE induced using myelin oligodendrocyte glycoprotein
(MOG) exhibit neurological disability (visual impairment and hind limb paralysis) and white
matter pathologies (i.e., inflammation, axonal injury, and demyelination) in the optic nerve and
spinal cord similar to MS [23-28].
In the present work, DBSI [21] and conventional DTI [29] analyses were performed to
assess optic nerve pathology in MOG-induced EAE-affected mice and sham mice at the onset of
ON, defined by the first sign of decreased VA. Following imaging, mice were sacrificed and
optic nerve tissues were examined by immunohistochemistry (IHC). The results demonstrated
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that inflammation, axonal injury and demyelination all correlated well with visual impairment at
onset of ON. DBSI detected inflammatory cell infiltration and optic nerve pathology in EAE
mice that was consistent with histology, supporting the potential use of DBSI to quantify
cellularity, axonal injury and myelin damage in other systems of human disease.

4.2 Materials and Methods
4.2.1 Animals
All procedures involving animals were performed according to the animal protocols
approved by the Washington University Animal Studies Committee and in compliance with
University policies and procedures on research involving animals.
EAE was induced in 8-week-old female C57BL/6 mice (Jackson Laboratory, Bar Harbor,
ME, USA) by subcutaneous immunization with 50 μg myelin oligodendrocyte glycoprotein
peptide (MOG35-55) emulsified in incomplete Freund’s adjuvant (IFA) containing 50 μg
Mycobacterium tuberculosis (MTB), as previously described [30]. Age-matched mice
immunized with IFA lacking MOG35-55 and MTB served as controls. Pertussis toxin (300 ng;
PTX, List Laboratories, Campbell, CA) was injected intravenously on days 0 and 2 postimmunization for EAE and PBS for sham mice. In this study, 10 EAE and 10 sham mice were
employed to establish the temporal visual function profile without undergoing MRI. Another
cohort of 16 EAE and 5 sham mice was employed to perform MRI measurements when mice
with first sign of decreased VA. Optic nerve tissues from 7 EAE and 5 sham mice were perfusion
fixed after MRI for histology. Mice were evaluated daily for clinical score using a published 0-5
clinical scoring system: 0, healthy; 1, limp tail; 2, hind limb weakness sufficient to impair
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righting; 3, one limb paralyzed; 4, two limbs paralyzed; 5, more than two limb paralyzed or the
animal is moribund [31], and VA assessment by virtual optomotor system [32, 33].
Significantly decreased VA was seen in one or both eyes in all EAE-affected mice in this
study. While all unilaterally affected optic nerves from EAE mice were included, only one optic
nerve per animal was randomly selected from the bilaterally affected and the sham-treated
animals for statistical analysis.

4.2.2 Optokinetic Tracking Responses
The visual function was assessed daily by optokinetic tracking response (OKR) using a
commercially available apparatus and the associated software, OptoMotry (Cerebral Mechanics,
Inc., Canada), as described [32, 33]. Briefly, mice were placed on a platform in a closed chamber
with a projection of virtual cylinders of varying spatial frequency at 100% contrast. The spatial
frequency of the rotating columns was noted at the point when the mouse responded to the
rotating columns by moving its head. In this study, VA was defined as the highest spatial
frequency, in cycles/degree (c/d), to which the mouse responded.

Each mouse eye was

independently assessed by changing the rotating direction of the cylinder, i.e., clockwise for left
(L) and counterclockwise for right (R) eyes. The baseline VA of each mouse eye was assessed
before EAE immunization. Two researchers measured the daily VA for each mouse eye in a
blinded fashion.

4.2.3 Magnetic Resonance Imaging
When decreased VA of the mouse eye was confirmed, in vivo diffusion MRI experiments
were performed on a 4.7-T Agilent DirectDrive™ small-animal MRI system (Agilent
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Technologies, Santa Clara, CA) equipped with Magnex/Agilent HD imaging gradient coil
(Magnex/Agilent, Oxford, UK) with pulse gradient strength up to 58 G/cm and a gradient rise
time ≤ 295 µs. For this, mice underwent 1 % isoflurane/oxygen anesthesia and were placed in a
custom-built head holder. Respiratory rate and rectal temperature, maintained at 37 ºC, were
monitored and controlled by a small animal physiological monitoring system (SAII Inc., NY).
An actively-decoupled volume (transmit) /surface (receive) coil pair was used for MR excitation
and signal reception, and all image slices were acquired based on previously reported procedures
[34]. A final-targeted slice provided a transverse view of mouse brain with the two optic nerves.
Diffusion weighted MRI was performed using a multi-echo spin-echo diffusion-weighted
sequence [35] with a 25-direction icosahedral sampling scheme [36]. The MR acquisition
parameters were: TR 1.5 sec, TE 37 ms, Δ 18 ms, δ 6 ms, field-of-view 22.5 mm × 22.5 mm,
data matrix 192 × 192, slice thickness 0.8 mm, and 1 average. The b-values used were distributed
from 0 to 2200 s/mm2, and the total acquisition was 2 hours and 20 minutes.

4.4.4 MR Data Analysis
The acquired diffusion data were analyzed by DBSI to derive axial diffusivity (λ║), radial
diffusivity (λ), fractional anisotropy (FA), fiber mean diffusivity (fiber MD), restricted isotropic
diffusion fraction (reflecting cells) and non-restricted isotropic diffusion fraction (reflecting
extra-axonal and extracellular space) as previously described [21]. Same data were also analyzed
using the conventional DTI to calculate λ║, λ, FA and MD [37, 38]. Mouse optic nerve crosssectional area was estimated by intensity segmentation of the diffusion-weighted image, with
diffusion sensitizing gradient perpendicular to optic nerves. Regions of interest (ROI) for DBSI
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and DTI comparisons were selected using both diffusion-weighted images and FA maps to
ensure consistency in ROI selection between animals.

4.2.5 Histological Analysis
Mice were perfusion fixed with 0.01 M phosphate-buffered saline (PBS) followed by 4%
paraformaldehyde in 0.01 M PBS immediately after MR imaging. The brains were excised and
placed in the fixative containing 4% paraformaldehyde in 0.01M PBS for 24 hours before
transferred to 0.01 M PBS for storage at 4 ºC until histological analysis. Fixed optic nerves were
embedded in 2% agar gel [39] and paraffin followed by sectioning into 5-µm thick transverse
slices. Sectioned tissues were deparaffinized, rehydrated, and blocked using a 1:1 mixture of
10% normal goat serum and 2% bovine serum albumin in PBS for 20 minutes at room
temperature to prevent nonspecific binding of goat secondary antibody. Sections were incubated
in monoclonal anti-phosphorylated neurofilament antibody (SMI-31; 1:1000, Covance, US) to
stain non-injured axons, or in rabbit anti-myelin basic protein (MBP) antibody (1:1000, Sigma
Inc., MO) to target myelin sheaths at 4 ºC overnight. After several rinses, secondary goat antimouse IgG and goat anti-rabbit IgG conjugated Alexa 488 (1:800, Invitrogen) were applied
respectively at room temperature for 1 hour to visualize the immunoreactivity. After washing,
slides were covered using Vectashield Mounting Medium with 4´,6-diamidino-2-phenylindole
(DAPI) (Vector Laboratory, Inc., Burlingame, CA) to stain cell nuclei. A Nikon Eclipse 80i
fluorescence microscope was used to examined and photograph the IHC-stained optic nerves
with the MetaMorph software (Universal Imaging Corporation, Sunnyvale, CA). Tissue sections
stained with the same primary antibody were acquired using identical fluorescence light intensity
and exposure time. Quantification of the SMI-31-stained intact axons and MBP-stained myelin
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sheaths (reflecting integrity of axon and myelin sheaths, respectively) was performed using two
photographs of each staining at 60x magnification. DAPI-stained cell nuclei were counted using
the entire optic nerve at 20x magnification. The IHC quantification protocols were adapted using
ImageJ [40] and gray level watershed segmentation (http://bigwww.epfl.ch/sage/soft/watershed/)
for assessment of optic nerve integrity.

4.2.6 Statistical Analysis
All data were expressed as mean ± standard deviation (SD). The Wilcoxon two-sample
test was used to assess the difference for each measured parameter between 16 eyes from mice
with ON and 5 sham eyes based on the median. A statistically significant difference was
accepted at 95% confidence level. The Spearman rank correlation coefficients with significant
test were calculated between VA and diffusion MRI measured parameters or IHC, and between
IHC and diffusion MRI parameters. All statistical analyses were performed using SAS V9.3
(SAS Inc., Cary, NC).

4.3 Results
4.3.1 Visual Acuity
An initial experiment was performed on a cohort of 10 mice immunized to develop EAE
and 10 sham-immunized mice to define the clinical course of ON due to EAE over time. The
clinical onset (CS = 1) of individual EAE mice was generally observed between day 11 and 13
after immunization, peaking at approximately day 17 (CS = 2.8 ± 1.1). Sham-immunized mice
exhibited no clinical signs (CS = 0). The onset of ON in EAE mice was defined as VA ≤ 0.25 c/d
(a threshold when the VA is 3 × SD below the mean VA of the sham eyes). Based on this
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operational definition, ON onset occurred between day 9 and 13 after immunization (Fig. 1).
Daily VA of sham eyes (n = 20) was unchanged longitudinally (0.38 ± 0.03 c/d) whereas the VA
of EAE-affected eyes decreased, with continued worsening of visual function reaching nadir at
day 20. A transient recovery of VA was seen between days 20 – 30, and 30 – 40, followed by
progressive decline of visual function after day 40 (Fig. 1). Among 10 EAE-affected mice in this
group, unilateral and bilateral ON was seen in 8 (80%) and 2 mice (20%), respectively.
After defining the onset of ON due to EAE in C5BL/6 mice in the first experiment
without MRI (Fig 1), a follow-up experiment comparing EAE-affected and sham mice was
performed to include MRI examinations at the onset of ON (days 9 – 13 after immunization). In
this experiment, VA at the onset of ON was much lower than the operational threshold.
Specifically, VA of the ON eyes from EAE-affected mice was 0.15 ± 0.11 c/d (n = 16), whereas
the VA of the sham mice were 0.37 ± 0.03 c/d (n = 5), similar to VA of sham mice in
Experiment 1 (Fig. 2).
Among the EAE mice with unilateral ON (n = 11; 69%) undergoing MRI in the second
experiment, the contralateral eye exhibited significantly reduced VA (0.33 ± 0.03 c/d; n = 11)
even though it did not meet the operational definition of ON in this study.
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Figure 4 – 1 Time course of visual acuity (VA) for eyes from EAE (open symbols, n = 20) and
sham (filled symbols, n = 20) mice. VA of sham eyes was unchanged throughout the time course
whereas VA of EAE eyes decreased starting at approximately day 9 after immunization. A
transient recover of VA was seen between days 20 – 30, and 30 – 40, followed by progressive
degradation of visual function after day 40. Based on the group averaged VA of sham eyes (0.38
± 0.03 c/d), a VA threshold was defined as the operational threshold to define the acute onset of
ON when VA ≤ 0.25 c/d. The onset of ON typically occurred during day 9 to 13 after
immunization.
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Figure 4 – 2 Group comparison of VA for sham and EAE eyes at the onset of ON exhibited a
wide range of VA at the onset of the disease. The group averaged VA was: 0.15 ± 0.11 vs. 0.37 ±
0.03 c/d for EAE ON (n = 16) vs. sham eye (n = 5).
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4.3.2 Optic nerve MRI
Representative in vivo diffusion-weighted images and corresponding DTI and DBSI
derived parameter maps exhibited changes in optic nerves from EAE mice with ON compared
with optic nerves of the sham group (Fig. 3). Results are summarized in Table 1. Optic nerve
cross-sectional area was increased in EAE mice with ON (65 ± 15 ×10-3 mm2, n = 16, Fig. 3A)
compared with sham optic nerves (51 ± 2 ×10-3 mm2, n = 5; P < 0.002, Table 1) at onset of ON.
Optic nerve λ║ (1.51 ± 0.29 µm2/ms, Fig. 3B) in EAE mice with ON was significantly decreased
compared with sham mice (1.89 ± 0.09 µm2/ms; P < 0.002, Table 1) using DTI. In contrast,
DBSI derived optic nerve λ║ (1.93 ± 0.23 µm2/ms, Fig. 3D) was not significantly decreased
compared with the sham mice (2.10 ± 0.04 µm2/ms; P > 0.1, Table 1). Optic nerve λ of mice
with ON was significantly increased whether derived by DTI (0.20 ± 0.04 µm2/ms) or by DBSI
(0.14 ± 0.03 µm2/ms; Table 1) compared with that of the sham group (DTI: 0.11 ± 0.01 µm2/ms,
Fig. 3C; DBSI: 0.11 ± 0.01 µm2/ms, Fig. 3E). Additionally, the DBSI derived restricted isotropic
diffusion component increased in the optic nerves of mice with ON (0.07 ± 0.06 vs. 0.03 ± 0.01
for controls, Fig. 3F; P < 0.02, Table 1). Similarly, the DBSI derived non-restricted diffusion
component in the optic nerves of EAE mice with ON (0.14 ± 0.04) also increased comparing
with the controls (0.03 ± 0.01, Fig. 3G, P < 0.002, Table 1). The DTI derived MD in optic nerves
of EAE mice with ON (0.64 ± 0.09 µm2/ms) was lower than that of the sham optic nerves, but
did not reach statistical significance (0.70 ± 0.03 µm2/ms; P > 0.09, Table 1). All DTI and DBSI
parameters correlated with VA (Table 2).
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Figure 4 – 3 Representatives of in vivo diffusion weighted image (A) and the corresponding DTI
(B, C) and DBSI (D-G) index maps of the optic nerve from EAE and sham mice. Increased
cross-sectional area at the onset of ON may be a consequence of the inflammation (cell
infiltration and vasogenic edema) of optic nerve (A). Decreased λ║ and increased λ derived by
DTI and DBSI was seen in the EAE eye of ON suggesting axonal and myelin damage (B – E).
DTI derived λ║ was slightly lower than that derived by DBSI, likely resulting from the
confounding effect of inflammation, i.e. cellularity and vasogenic edema. Heterogeneity of DTI
derived λ║ was apparent (B), overall lower than that of DBSI (D), was largely in parallel with the
intensity distribution of DBSI derived restricted diffusion fraction map (F). The significantly
decreased DTI derived λ║ closely corresponded with the increased restricted diffusion fraction
(putatively reflecting increased cellularity). DBSI derived λ║ was independent of cellularity
changes (B, F). Both DTI and DBSI derived λ increased (suggesting myelin damage; C and E)
in optic nerves from EAE compared with sham mice. DBSI derived non-restricted diffusion
fraction (G) did not change appreciably in this EAE mouse except at the periphery of the nerve
(a potential contamination of cerebrospinal fluid surrounding the optic nerve). Note, the
contamination of CSF was removed from all other parameters by DBSI.
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Table 4 – 1 Summary of median (Q1, Q3) for MR derived parameters in EAE with ON and
Sham eyes at the onset of ON
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Table 4 – 2 Summary of visual acuity correlations for MR derived parameters and
immunohistochemistry of optic nerve in EAE with ON and sham eyes at onset of ON
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4.3.3 Immunohistochemistry of optic nerve
Post-MRI optic nerve sections exhibited a heterogeneous overall increase in DAPIpositive (blue color) nuclear staining in the optic nerve from a representative EAE mouse at the
onset of ON compared with those of a representative sham mouse (Fig. 4A). Both SMI-31 and
MBP staining were examined from the center of the optic nerve at 60× magnification,
corresponding to the highlighted regions of the 20× magnified DAPI images (gray rectangle). A
decrease in SMI-31-positive (green color) healthy axons and MBP-positive (red color)
myelinated axons was also seen in the optic nerve from an MOG35-55 -immunized mouse with
ON compared with the sham optic nerve (Fig. 4B and C). A statistically significant increase in
DAPI-positive counts was seen in optic nerve of EAE mice with ON (6.6 ± 4.1 × 103 per mm2, n
= 7) comparing with that of the sham (3.5 ± 0.7 × 103 per mm2, n = 5, P < 0.05; Fig. 4D). Axon
and myelin integrity assessed by SMI-31 (Fig. 4E), and MBP (Fig. 4F) was significantly
decreased in the optic nerves of EAE mice with ON (SMI-31: 5.7 ± 1.7 × 105 vs. 7.4 ± 0.3 × 105
per mm2, P < 0.01; MBP: 36 ± 4 vs. 45 ± 3 in area%, P < 0.01).

4.3.4 Correlating DTI and DBSI with immunohistochemistry
Both DTI (r = 0.86, P = 0.0003; Fig. 5A) and DBSI (r = 0.73, P = 0.0071; Fig. 5D)
derived λ║ significantly correlated with SMI-31-positive axon counts in optic nerves from both
EAE with ON (n = 7) and sham (n = 5). Similarly, both DTI (r = -0.83, P = 0.0008; Fig. 5B) and
DBSI (r = -0.85, P = 0.0005; Fig. 5E) derived λ negatively correlated with MBP-positive
staining. The DTI derived MD decreased with increasing DAPI counts (r = -0.82, P = 0.001; Fig.
5C). DBSI derived restricted isotropic diffusion fraction (putative cellularity marker derived by
DBSI) significantly correlated with DAPI counts (r = 0.81, P = 0.0013; Fig. 5F).
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Figure 4 – 4 Representative immunohistochemistry staining of optic nerves from mice at onset
of ON after MRI, same nerves as seen in Fig. 3. DAPI-positive staining (A) matched the
restricted isotropic diffusion fraction in Fig. 3F of the optic nerve from the EAE mouse. Both
SMI-31-positive staining (reflecting axonal integrity; B) and MBP-positive myelin sheaths
(reflecting myelin integrity; C) were examined from the center of the optic nerve at 60×
magnification, highlighted in A (gray rectangle), revealed discernible loss of staining intensity
suggesting both axon and myelin damage. Quantification of staining results clearly shows
inflammation (D), axonal injury (E), and demyelination (F) coexisted and were significant at the
onset of ON. Scale bar = 50 µm.
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Figure 4 – 5 Correlations between DTI and DBSI derived λ║ with SMI-31 positive axon counts
(A, D), DTI and DBSI derived λ and MBP positive area (B, E), DTI derived MD and DAPI
positive nuclei counts (C), and DBSI derived restricted diffusion fraction and DAPI positive
nuclei counts in EAE (n = 7, open circle) and sham eye (n = 5, black triangle). Both DTI and
DBSI derived λ║ and λ significantly correlated with SMI-31 and MBP respectively (A and D, B
and E). The decreased DTI derived MD strongly correlated with increased DAPI counts, clearly
demonstrating the impact of inflammation on DTI derived diffusivity (C). The increase in
restricted isotropic diffusion fraction also correlated with increased DAPI counts (F). Results
suggested that both DTI and DBSI derived λ║ and λ are sensitive to optic nerve pathologies at
the onset of ON. However, inflammation associated cellularity confounded DTI derived
diffusivity thus could lead to false positive conclusion due to underestimation of λ║ and MD.
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4.4 Discussion
In this paper, we use a virtual optomotor system to longitudinally assess optic nerve
function in ON due to MOG35-55 -induced EAE in C57BL/6 female mice. The method was
sensitive to reduced visual acuity in mice, as confirmed by histopathology, and allowed detection
of early clinical ON. ON was almost universal in EAE-affected mice, preceding other clinical
signs of EAE by 2 or more days in most cases. We then demonstrated the use of a new imaging
method, DBSI, to simultaneously detect inflammation, demyelination, and axonal injury in live
mice with acute ON detect by the virtual optomotor system. We compared DBSI to conventional
DTI in the assessment of acute ON in mice and correlated results using each technique with
measures of axon integrity, myelin integrity and cellular infiltration determined by
immunohistochemistry.
Results demonstrated that both DTI and DBSI derived λ║ (decreased, reflecting axonal
injury) and λ (increased, reflecting myelin damage) correlated with VA and with axon (SMI-31
vs. λ║) and myelin (MBP vs. λ) integrity assessed with IHC. Unlike DTI, DBSI can measure
restricted (putatively reflecting cells) and non-restricted (putatively reflecting vasogenic edema)
isotropic diffusion tensor fractions. These isotropic fractions were each significantly increased in
the optic nerves of mice during acute ON. Consistent with the initial report (Wang et al., 2011),
the increased fraction of restricted diffusion tensor component correlated well with increased
cellularity assessed by DAPI staining. These data further supported the potential of DBSI as a
tool to measure cellularity associated with inflammation. The effects of inflammation associated
increase in cellularity and edema to confound DTI derived parameters was evident.
Many reports have demonstrated the effect of inflammation on MRI findings [15, 18, 20,
41, 42]. For example, the optic nerve cross-sectional area has been shown to detect optic nerve
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inflammation in ON patients [15, 43]. Our observation of a significant increase in optic nerve
cross-sectional area in acute ON due to EAE (Fig. 3A and Table 1) was consistent with previous
reports in ON patients. However, increased optic nerve cross-sectional area [15] is not specific to
a particular pathology, and is likely the result of both increased cellularity and edema. Changes
seen in optic nerve cross-sectional area may also be confounded by concurrent tissue loss due to
axonal degeneration.
Prior studies have reported DTI derived diffusivity and anisotropy measures in optic
nerves of ON-affected mice and humans that were not always as expected [20, 24, 44]. Despite
the prevailing notion that axon loss is the main determinant of long-term disability, radial
diffusivity, a putative marker of myelin loss, correlated best with visual recovery in human ON
using DTI [20]. It is likely that the increased DTI-derived radial diffusivity seen in optic nerves
of eyes with remote ON is due to a combination of demyelination and also increased isotropic
diffusion due to axon loss.
The impact of isotropic components of inflammation, i.e., inflammatory cell infiltration
and vasogenic edema, on DTI derived parameters was observed in the current study. Despite the
same trend of changes in both DTI and DBSI derived λ║ and λ in the optic nerve of EAE mice
at ON onset, DTI derived λ║ was lower and λ was higher than that derived by DBSI (Table 1).
The underestimation of DTI derived λ║ in the optic nerve of EAE mice could be due to the
contribution of restricted diffusion of the increased cellularity [21, 45]. The overestimation of
DTI derived λ, in contrast, was likely the effect of increased vasogenic edema [46, 47]. This is
consistent with our histological findings, and also with the DBSI results revealing the increased
isotropic fractions of restricted diffusion (cellularity) and high diffusion (vasogenic edema) in the
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optic nerve of EAE mice at ON onset. These pathological findings have also been observed by
others using conventional histology [25, 26].
In addition to the directional diffusivity, the effect of increased cellularity and edema was
also seen in both DTI derived MD and FA (Table 1). The significantly decreased FA was a result
of the synergistic effect of the increased cellularity [21] and vasogenic edema [46, 47] while the
less significantly decreased MD was a result of the opposite effect of increased cellularity
(decrease MD) and vasogenic edema (increased MD). In the current study, increased cellularity
seemed to dominate the diffusion MRI parameters in the optic nerve of EAE mice at the ON
onset, supported by the strong negative correlation between MD and DAPI positive nuclei counts
(r = -0.82, P = 0.001; Fig. 5C), and strong positive correlation between DBSI derived restricted
diffusion fraction and DAPI counts (r = 0.81, P = 0.0013; Fig. 5F).
Our findings from diffusion MRI and IHC were consistent with the presence of axonal
injury early in MS/EAE. Inflammation, demyelination, and axonal injury were all observed in
the optic nerves at the onset of ON. All MRI and IHC measured optic nerve pathology markers
correlated with VA (Table 2) at the onset of ON, suggesting the injured optic nerve indeed
contributed to the visual functional deficit. Our pilot results revealed no loss of RGC cells
(determined using FluoroGold injected stereotactically into superior colliculi followed by RGC
counts at day 10 - 12 post-immunization) in EAE mice at ON onset, 387 ± 11 (n = 7, EAE) vs.
395 ± 14 (n = 5, sham), and preliminary analysis revealed no changes in thickness of the retina
(203 ± 7 for EAE, n = 6 vs. 200 ± 13 µm for sham, n = 6). Although not definitive, our pilot data
suggested that there was no RGC loss or retinal thickness change (swelling or atrophy) at the
onset of ON to account for the visual loss. Instead, the present study implicates a retrograde optic
nerve degeneration leading to RGC loss and retinal atrophy as the disease progresses [25, 48].
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This could be consistent with the gradual decline in vision observed in the longitudinal
experiment after 35 days post-immunization.
In conclusion, both DTI and DBSI were able to reflect visual function measured by VA.
However, the underlying pathological specificity was lost in DTI in the presence of inflammation
due to the confounding effects of the associated increase in cellularity and vasogenic edema. In
contrast, DBSI was able to discern and measure these inflammation-related pathologies. The
current study clearly demonstrated the advantage of DBSI in specifically detecting and
distinguishing inflammation, demyelination, and axonal injury in optic nerves of EAE mice at
the onset of ON. Application of DBSI to human CNS imaging may expand the ability to detect
and characterize inflammation.
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Chapter 5
Conclusions

5.1 Conclusions
Visual dysfunction in multiple sclerosis (MS), commonly the first clinical symptom, is
caused by optic neuritis (ON), an inflammation of optic nerve [1, 2]. Thus, functional deficits
and structural changes in the visual pathway of ON have been extensively examined [3].
Although various MR techniques have been used to assess inflammation (inflammatory cell
infiltration and vasogenic edema) of ON, they rarely demonstrated the ability to image cellularity
changes non-invasively [4-7]. This current work has attempted to establish a more accurate
measure to assess disease pathologies than the conventional MRI approaches in the hopes of
better understanding the disease progression and predicting the various courses of MS.
Neurodegeneration in ON was generally thought to be caused by an inflammatory
process of optic nerve, resulting in demyelination and axonal damage, and eventually neuronal
loss [8, 9]. Accumulated axonal damage was considered as the major correlate of permanent
disability [10]. Therefore, a non-invasive, specific biomarker for inflammation or cellularity may
provide a window to reflect disease progression in MS. Our recently developed diffusion basis
spectrum imaging (DBSI) approach has shown the capability to assess inflammation, cellularity,
axonal injury and demyelination in CNS white matter [11]. Experimental autoimmune
encephalomyelitis (EAE), an animal model of MS [3], mimics several MS-like stages and
characteristics and thus provides a model to investigate the ON-associated neuropathology in
MS.
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To demonstrate that our approach accurately reflects inflammation or cellularity, the
histological validation is necessary. Therefore, correct and reliable histological staining and
quantification protocols are important. As described in Chapter 2, we optimized a set of high
quality immunohistochemical staining methods. At the same time, systematic and objective
quantification protocols were developed, which are successful in evaluating intact and injured
axons, myelin sheaths, and cell nuclei. The histological results by the newly developed protocols
are highly reliable.
The impact of CSF partial volume, edema, and inflammation on DTI has been longrecognized; while DBSI enables resolution of these pathologies using a multi-tensor model with
multi b-values. In addition, by taking advantage of the coherence of white matter tracts, DBSI
allows us to use a reduced diffusion-encoding scheme as applied herein on optic nerve. In
Chapter 3, we employed a tissue phantom with 2% agar gel to mimic the condition of vasogenic
edema to compare DBSI [11] and conventional DTI [12] measurements. The results showed
DBSI provides reliable fiber diffusivity under conditions where DTI fails. A Monte-Carlo
simulation considering the impact of edema agrees with the experimental results. The impact of
cellularity on DTI and DBSI was further evaluated using simulation as well. Moreover, a 25direction encoding scheme [13] was successfully applied to generate high quality images of the
mouse optic nerve without compromising the accuracy of DBSI analysis.
Finally, Chapter 4 first described the visual acuity (VA) time course of sham and EAEaffected mice where the first sign of decreased VA was detected in EAE and the VA threshold
with onset of ON was operationally defined. Second, both DBSI [11] and DTI [12] were
performed to assess optic nerve pathologies from EAE and sham mice at onset of ON using the
25-direction diffusion-encoding scheme [13], followed by immunohistochemistry using the
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developed protocols from Chapter 2. Our results demonstrate that inflammation correlated well
with visual impairment in acute EAE ON without retinal atrophy. DBSI successfully detected
inflammatory cell infiltration and optic nerve white matter pathology in EAE that was consistent
with histology, supporting the capability of DBSI to quantify increased cellularity, axonal injury
and myelin damage in the optic nerve of EAE mice.
Overall, the work supports the contention that DBSI provides non-invasive, specific
biomarkers of inflammation, cellularity, axonal damage and demyelination in a mouse model of
MS by DBSI-derived restricted and non-restricted isotropic diffusion fractions, and axial and
radial diffusivity. DBSI can therefore accurately reflect the disease progression.
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Fig.1 (a) In vivo acute DTI derived ADC
maps of craniotomy, mild and moderate
stroke mice are shown at three different
positions: anterior, middle, and posterior
of mouse brain. The total infarct volume
(b) and its ADC value (c) were quantified.
The infarct volume increases rapidly with
increase of injury severity while ADC
shows no difference between the two
injury groups.
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Introduction
Rodent models have been employed to study human stroke, the third leading cause of death and
disability in western countries. In vivo magnetic resonance (MR) imaging including advanced
diffusion technology has been employed to examine infracted tissues after stroke1. The decreased
apparent diffusion coefficient (ADC) has been demonstrated as a sensitive and reliable biomarker
of cerebral ischemia2-3. In addition, there have been efforts to correlate MR findings with
neurological behavior outcomes. Various behavior assessments have been employed including
neurological scoring system4, rotor rod5, and methamphetamine-induced rotation test5. However, an
accurate behavior test avoiding subjective ratings, significant training effect, or injection of
medicine is still needed. Footprint analysis is a simple and sensitive measurement for gait analysis
and has been applied to objectively evaluate the step cycle of mice6,7. In this study, the gait analysis
of middle cerebral artery occlusion (MCAO) mice was performed using a treadmill to examine the
effect of lesion severity on neurological function. Acute DTI derived ADC delineated ischemic
lesion clearly enabling quantification of the lesion volume and lesion ADC. The ADC defined
lesion volume correlated well with injury severity, and neurological motor function.
Methods
Eighteen male, 8 – 12 weeks old, C57BL/6 mice weighing between 20 – 28 g underwent
different degrees of stroke injuries (n = 6 for each group) by electrocoagulation of middle cerebral
artery at the right side of the mouse brain. The injury severity was regulated by controlling energy
of electrocoagulation at 0 (craniotomy), 1.4 (mild), and 1.8 mJ (moderate). In vivo DTI was
immediately performed on a 4.7 T magnet utilizing a standard spin-echo diffusion-weighted
sequence. All images were obtained with acquisition parameters of TR 1.7 sec, TE 50 ms, Δ 25 ms,
δ 8 ms, NEX 4, slice thickness 0.5 mm, field-of-view 3.0 cm × 3.0 cm, data matrix 256 × 256 (zero
filled to 512 × 512), (Gx,Gy,Gz) = (1,1,0), (1,0,1), (0,1,1), (-1,1,0), (0,-1,1), and (1,0,-1), and b = 0
and 0.768 ms/μm2. The locomotor function (left foot base) of the mice was assessed using the
treadmill with gait analysis software TreadScanTM 2.0 (Clever Sys. Inc., VA, USA). The evaluation
was performed at a speed of 15 cm/s without pre-training. The statistical analysis, two sample
student t test and Person-product linear correlation, was performed with Origin 7.5 SR2 v7.5817
(Origin Lab Co., MA, USA).
Results and Discussion
In acute stage, i.e., at 3 hours after stroke injury, the tensor derived ADC maps clearly
revealed the infracted cortex as the hypointense region on ADC maps in stroke mice. The region of
interest (ROI) analysis based on the ADC contrast between the infarct and the non-injured cortex
was used to quantify the total lesion volume (Fig. 1a). As the energy deposition elevated to increase
the injury severity, the infarct volume increased significantly (Fig. 1b). Although there was a
statistically significant difference between the stroke mice and the control, the ADC value of the
lesion area among the stroke groups were not statistically significantly different (Fig. 1c). The
result suggests that the lesion volume determined using the ADC correlated well with the injury
severity intended by modulating the deposited coagulation energy.
The left and right foot base, the distance between mid-points of strides of the pairs of
feet, was assessed using mouse treadmill as neurological functional measure. Prior to any
experimental procedure, there was no foot base difference among all mice as expected. Since we
did the surgery on the right side of the mouse brain and the infarct covers the motor and sensory
cortex, we expected a neurological deficit to the left side. Indeed, animal with ischemia showed
shortened left foot base compared to naïve and craniotomy group. A linear correlation between the
volume of acute infarction and left foot base at day 3 is observed (Fig. 2). There was no observable
foot base change for right lateral limbs (data not shown).
Conclusion
As previously reported1-5, in vivo diffusion examination of brain tissue sensitively
revealed ischemic lesion. Our results indicated that the total ADC determined volume of infarction
reflected stroke injury severity better than ADC itself. The acutely quantified infarct volume
correlated with the locomotor function deficit assessed using gait analysis of the mouse treadmill.
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1

C-W. Chiang1, J. Chen2, and S-K. Song3
Chemistry, Washington University in St. Louis, Saint Louis, MO, United States, 2Medicine, Washington University in St. Louis, Saint Louis, MO, United States,
3
Radiology, Washington University in St. Louis, Saint Louis, MO, United States

Introduction
Acute excitotoxicity causes cytotoxic edema
that precedes neuron cell necrosis and
apoptosis in neurological diseases1. Apparent
diffusion coefficient (ADC) decreases early
reflecting cytotoxic edema in various brain
injuries2. Our recent study demonstrated that
high-resolution diffusion MRI detected three
retinal layers of distinct ADC3. In this study,
we examined the feasibility of detecting Nmethyl-D-aspartate (NMDA) induced retinal
excitotoxic injury in mice using in vivo
diffusion MRI.

ADC (10-3 mm2/s)

Materials and Methods
Fig. 1 (A) A representative of non diffusion-weighted image of a normal mouse eye. The highlighted box
Animal Model: Eight-week old male C57BL/6 shows central retina close to the optic nerve head. (B) T2-weighted MR images of mouse retina at baseline
mice (~25 g) received 0.5 μl of 5 mM and PI 3-hour, 1-, 3-, 7-day. (C) Diffusion weighted MR images of the same mouse eyes. (D) H&E staining
NMDA/saline through intravitreal injection. of retina from the same mouse. Scale bar, 200 µm. PI – post injection.
In vivo diffusion MRI was performed at 3-hour
(n=6), 1- (n=5), 3- (n=3), and 7-day (n=4) post injection (PI). Baseline
(A) 1.0
(B )
NFL/GCL/IPL
*
measurements were performed on age-matched C57BL/6 male mice without NMDA
0.8
*
0.6
treatment (n=4). In vivo MRI: Diffusion weighted imaging (DWI) was performed on
0.4
11.74 T utilizing a standard spin-echo diffusion-weighted sequence. Three pairs of
0.2
0.0
diffusion weighted images with orthogonal diffusion weighting directions and
0.6
INL/OPL
opposite gradient polarity and a non-diffusion weighted image were acquired for
*
3
0.4
*
each mouse eye . MRI acquisition parameters were: TR 2 sec, TE 34 ms, Δ 15 ms, δ
*
0.2
5 ms, b = 0 and 955 s/mm2, slice thickness 400 μm, FOV 12 × 12 mm2, in-plain
2
2
0.0
resolution 47 × 47 μm (23 × 23 μm zero filled), and number of average 1. Mice
0.6
ONL/IS/OS
were euthanized at the conclusion of MRI. Eyes were enucleated and snap frozen for
0.4
histology. Data Analysis: Calculation of ADC map and identification of region of
0.2
interest were performed as previously reported3. Starting from the vitreous, the three
MR-detected retinal layers were assigned to NFL/GCL/IPL (dark) – INL/OPL
0.0
Baseline PI 3-hour PI 1-day PI 3-day PI 7-day
(bright) – ONL/IS/OS† (dark). At PI 1-day, there were three, two extra layers
resulting from NMDA toxicity, MR-detected layers in the middle and were
Fig. 2 (A) Diffusion weighted MRI determined ADC in
tentatively assigned as INL/OPL. Histology: Eight-μm thick tissue sections bisecting
NFL/GCL/IPL, INL/OPL, and ONL/IS/OS of mouse retina at
baseline and PI 3-hour, 1-, 3-, and 7-day. (B) H&E stained
the optic nerve were collected for hematoxylin and eosin (H&E) staining to examine
mouse retina shows corresponding retinal cell layers. *, p < 0.05
the changes of retinal layers. Statistics: One-way ANOVA was performed to test
compared to baseline.
ADC difference between NMDA-treated groups and baseline.
Results
Figure 1 shows MR images and the matched H&E staining of mouse retina with or without NMDA treatment. A hyper-intense inner retinal layer
between NFL and OPL was seen in DWI as early as at PI 3-hour. At PI 1-day, retinal swelling was evidenced by the increased number of MRdetected middle layers and the increased retinal thickness in H&E staining. At PI 3-day and 7-day, both the inner retinal hyperintensity and retinal
swelling subsided, possibly as a result of tissue loss. Figure 2 shows DWI determined ADC in respective MR-detected retinal layers. A transient
decrease of ADC in INL/OPL that peaked at PI 3-hour (~30%) was observed. In contrast, ADC in ONL/IS/OS exhibited no change at all times.
Additionally, ADC in NFL/GCL/IPL increased at PI 3-hour and 1-day.
Discussion and Conclusion
Intravitreal injection of NMDA caused a transient decrease of ADC in INL/OPL at PI 3-hour, the earliest measurement in our hands, suggesting the
excitotoxicity induced edema in these retinal layers4. ADC in ONL/IS/OS was not affected by NMDA treatment, reflecting the resistance of presynaptic photoreceptors to NMDA excitotoxicity5. The transient increase of ADC in NFL/GCL/IPL at PI 3-hour and PI 1-day could be attributed to
the acute necrosis of ganglion cells which are sensitive to excitotoxicity6. Overall, current results support that decreased ADC as a biomarker of
cytotoxic edema providing an early measure of retinal excitotoxicity injury before retinal swelling.
†, Abbreviations of retinal layers: NFL – nerve fiber layer; GCL – ganglion cell layer; IPL – inner plexiform layer; INL – inner nuclear layer;
OPL – outer plexiform layer; ONL – outer nuclear layer; IS – inner segment; OS – outer segment.
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Acute visual function impairment in EAE is primarily caused by optic nerve inflammation as assessed by DBSI
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Introduction
Experimental autoimmune encephalomyelitis (EAE) is the main animal
model of human multiple sclerosis. Optic neuritis is a commonly seen
A.
B.
pathology in EAE mice, and involves inflammation, demyelination, and
axonal damage. A prior histological study showed that inflammation
precedes retinal ganglion cell death in EAE.[1] Diffusion tensor imaging
(DTI) has previously detected axon and myelin injury as decreased axial
and increased radial diffusivity, respectively, in chronic EAE optic
nerve[2]. In this study, a novel diffusion basis spectrum imaging
(DBSI)[3] was performed to evaluate inflamed EAE-affected optic nerves
during acute EAE.
Fig. 1 A representative in vivo transverse view diffusion-weighted image of a
Materials and Methods
control mouse brain with optic nerves highlighted (A). Representative DBSI
Animal Model: EAE was induced in female, 8 – 10 week old C57BL/6 maps of control and EAE optic nerve demonstrating the extent of optic nerve
mice (~20g) by active immunization with MOG35-55 peptide/CFA inflammation are presented with color-coded intensity (B).
emulsion (n=15). In vivo diffusion MRI was immediately performed at
the first detection of impaired vision in mice, typically between 9 – 14 days after immunization. Age-matched control mice (n=5) underwent the same
procedure without MOG35-55 immunization. In vivo MRI: DBSI was performed on a 4.7 T magnet utilizing a multi-echo spin-echo diffusionweighted sequence by multi-directions and multi-b-values. All images were obtained with acquisition parameters of TR 1.5 sec, TE 37 ms, Δ 18 ms,
δ 6 ms, max. b-value 2,200 s/mm2, slice thickness 0.8 mm, field-of-view 22.5 mm × 22.5 mm, in-plain resolution 117 μm × 117 μm (59 μm × 59 μm
zero filled). Functional measurement: Visual acuity (VA) of the individual mouse eye was assessed using Virtual Optomotor System (OptoMotry,
Cerebral Mechanics Inc., Canada). Independent left-eye and right-eye vision was measured corresponding to clockwise and counter-clockwise
grating movement with adjustable spatial frequency[4]. Baseline VA measurement was assessed to confirm intact vision before EAE immunization.
Daily VA measurement was performed to determine EAE optic neuritis onset. Normal mice VA = 0.38 ± 0.03 c /d (mean ± SD). Poor mouse vision
was defined as VA≤ 0.25 c/d.
Results
Figure 1(A) shows diffusion-weighted image of control mouse brain with left and right optic nerve (see highlighted box). Figure 1(B) shows
representative DBSI maps of cell %, edema %, and inflammation % (equal to cell % + edema %) on control and acute EAE mice with decreased VA.
Cell inflammation, edema, and inflammation were clearly seen in acute EAE compared to control mice. Quantified DBSI index and DTI-derived
axial and radial diffusivity were shown in Figure 2 and 3. Figure 2 shows all three DBSI index linearly correlates with VA. A strong negative
correlation of edema with VA [R2 = 0.64; Figure 2(b)] and inflammation with VA [R2 = 0.80; Figure 2(c)] was seen in acute EAE mice. Figure 3(a)
shows that DTI- and DBSI-derived axial diffusivity in EAE mice were each significantly decreased compared with control mice. In contrast, Figure
3(b) shows that DTI- and DBSI-derived radial diffusivity in EAE each significantly increased compared with control mice.
Discussion and Conclusion
Our results indicate that in vivo DBSI-derived inflammation% significantly correlated with VA during acute EAE, supporting a predominant role of
inflammation at the onset of optic neuritis. The decreased axial diffusivity measured by both DTI and DBSI suggested accompanying axonal injury
during acute EAE. Immunohistochemistry is being performed on nerves fixed after MRI to evaluate cell infiltration, axonal injury, and myelin
integrity to compare and correlate with our in vivo MRI findings.
References
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(a)

(b)

(a)
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Fig. 2 Correlations between optic nerve DBSI indices and visual acuity (VA) of control (n=5)
and acute EAE mice with various degrees of VA impairments (n=15). (a) Cell %, (b) edema %,
and (c) inflammation % all negatively linearly correlated with mouse VA. DBSI-based
inflammation in optic nerves correlated strongly (R2 = 0.80) with mouse VA, suggesting
inflammation is a predominant factor leading to visual function impairment in acute EAE.
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(b)

Fig. 3 (a) DTI- and DBSI- derived axial diffusivities in acute
EAE decreased by 20% and 13% from the control level. (b) DTIand DBSI- derived radial diffusivities in acute EAE increased by
80% and 38% from the control level. *, p < 0.05 compared to
control.

Reduced Diffusion Encoding for Accurately Estimating Axonal Injury, Demyelination, and Inflammation in Mouse Optic
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Introduction
Diffusion tensor imaging (DTI) has been successfully used to detect axon/myelin dysfunction in white matter injury [1].
However, the Gaussian diffusion assumption hampered its application to quantify non-Gaussian characters. Many new
diffusion MRI techniques, such as generalized DTI (gDTI) [2], diffusion spectrum imaging (DSI) [3], diffusion kurtosis
imaging (DKI)[4], composite hindered and restricted model of diffusion (CHARMED) [5], have been proposed to model
the non-Gaussian diffusion in the past decade. We have recently developed a new diffusion MRI method, diffusion
basis spectrum imaging (DBSI), to resolve crossing fibers and quantify confounding effects of inflammation [6]. A 99direction diffusion-encoding scheme was employed for acquiring DBSI data providing sufficient information to
accurately detect and quantify multiple diffusion components including crossing fibers, axonal injury, demyelination,
and inflammation in both ex vivo phantom and an in vivo animal model [6]. However, the initial DBSI protocol with 99direction diffusion weighting scheme leads to a lengthy scanning time. To image small coherent white matter tract such
as mouse optic nerve, high spatial resolution and high SNR are required, significantly hampering in vivo DBSI
Figure 1 Original 99applications. Taking the advantage of the simple structure of optic nerve without crossing fibers, we removed the
direction scheme. Each
redundancy in the original 99-direction DBSI diffusion weighting scheme in this study. We demonstrated that a
diffusion-encoding
simplified 29-direction DBSI diffusion weighting scheme was adequate to generate DBSI results from mouse optic
vector starts from the
nerves that were comparable to those obtained using the full 99-direction diffusion-encoding scheme.
origin of the Cartesian
Method 99-direction DBSI scheme: Standard 99 DBSI diffusion-encoding directions can be visualized on a 3D
grid system and ends at
Cartesian grid system (blue boxes in Figure 1). Each diffusion-encoding vector starts from the origin of the Cartesian
a non-origin grid point
grid system and ends at a non-origin grid point (colored arrows) including (1) 93 diffusion-encoding vectors located
(colored arrows).
inside the sphere of radius = 3 and (2) 6 diffusion-encoding vectors located at the crossing points between the
Cartesian axes and the sphere which constitutes the 99-direction DBSI diffusion-encoding scheme. DBSI diffusionencoding scheme is the same as the grid scheme used in DSI [3]. However, DBSI only uses the inner part of the DSI
grid scheme. The maximal diffusion weighting factor (b-value) of DBSI scheme was 3200 s/mm2 for ex vivo studies.
Simplified 29-direction DBSI scheme: The simplified 29-direction diffusion weighting scheme (blue arrows with red
circles at the tip in Figure 2) was selected and derived from the original 99-direction scheme (blue arrows in Figure 1)
by removing symmetric or redundant diffusion-encoding directions while maintaining the diffusion space well sampled
and the b-value fully distributed from the range of 0 to 3200 s/mm2 for ex vivo studies.
DBSI scan of fixed optic nerves of experimental autoimmune encephalomyelitis (EAE)-affected mice: Five fixed,
female EAE-affected C57BL/6 mouse brains with individual paired optic nerves, four mice at acute stage and one at
chronic stage with severe pathologies, were examined with both 99- and 29-direction DBSI at the same experimental
setup on a 4.7 Tesla scanner using multiple-echo spin-echo sequence [7] with the following parameters: TR 1.2 s, TE
38 ms, Δ 15 ms, δ 5 ms, field-of-view 20 mm × 20 mm, data matrix 256 × 256 (before zero-filled), slice thickness 1 mm,
Figure 2 New 291 average, and maximal b-value 3200 s/mm2. Total acquisition time for 99- and 29-direction DBSI was 8 h 25 min and
direction scheme (blue
2 h 30 min respectively. Voxel-based analysis was performed on non-zero filled 99- and 29-direction DBSI data, 50
arrows with red marks)
voxels from 10 optic nerves were used for comparison.
is simplified from the
DBSI analysis: Eq. [1] was solved by fitting the 99 (or 29)
99-direction scheme
diffusion weighted signals using a linear combination of
(blue arrows).
diffusion basis sets consisting of cylindrically symmetric
diffusion tensors [3] with the freedom to vary λ|| and λ⊥ to
estimate the number of anisotropic diffusion tensor components
(Naniso) and the associated principal directions. After NAniso was
computed, the number of isotropic component (Niso) was further
determined using nonnegative least-squares (NNLS) analysis. The
global nonlinear optimization was conducted employing direct
pattern search to solve Eq. [1]. Sk is the kth measured diffusion
weighted signals (k = 1, 2, 3, …). Si and Sj are fractions of
anisotropic diffusion components and isotropic diffusion component
Figure 3 29- and 99-direction DBSI indices distributed close to the
respectively.
line of identity, indicating minor offsets using 29-direction scheme.
Results and Discussion
Scatter plots (Fig. 3 a-e) qualitatively revealed that most data points
distributed near the line of identity with small offsets. Bland-Altman analysis
(Table 1) quantitatively suggested that 29- and 99-direction DBSI indices
were comparable with acceptable standard deviations of the difference and
small biases. For the animal tissues demonstrated in this study, the scanning
time was reduced by 2/3rds using the simplified 29-direction DBSI compared
to the original 99-direction scheme. The same spatial resolution and DBSI
computation accuracy was maintained for mouse optic nerves ex vivo.
Currently, by employing single-shot diffusion-weighted EPI, 99-direction
Table 1 Quantitative Bland-Altman analysis of the simplified
DBSI with 2 x 2 x 2 mm3 resolution can be acquired within 15 min on a 3.0
29- and original 99-direction DBSI, indicating good
Tesla Trio TIM (Siemens, Erlangen, Germany) human scanner. If the same 2
agreement between the two schemes.
x 2 x 2 mm3 resolution is maintained, the simplified 29-direction scheme will
shorten the scanning time to 5 minutes.
References [1] Song, SK. et al. Neuroimage 2002; 17:1429 . [2] Chunlei L. et al. MRM 2004; 51:924–937; [3] Wedeen, VJ. et al. Neuroimage 2008; 41:
1267-77; [4] Fieremans, E. et al. Neuroimage 2011; 58:177-188; [5] Assaf,Y. et al. Neuroimage 2005; 27: 48-58; [6] Wang,Y. et al. Brain 2011,
134:3590; [7] Tu TW. et al. Proc. Intl. Soc. Magn. Reson. Med. 18 (2010), 4001.
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Cell Swelling Contributes to Thickening of Low-Dose Nmethyl-D-Aspartate–Induced Retinal Edema
Junjie Chen,1,4 Chia-Wen Chiang,2,4 Huiying Zhang,1 and Sheng-Kwei Song3
PURPOSE. The contribution of cell swelling versus vascular
leakage in retinal edema remains largely undefined. The
objective of this study was to use in vivo magnetic resonance
imaging (MRI) to assess retinal cell swelling in the edematous
mouse retina.
METHODS. Inner retinal edema was induced by intravitreal
injection of 2.5 nmol N-methyl-D-aspartate (NMDA). To assess
retinal cell swelling, diffusion MRI was performed at baseline,
3-hours, 1 day, 3 days, and 7 days (n ‡ 5 at each time point)
after NMDA injection. To detect retinal vascular leakage,
gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA)
enhanced MRI was performed at baseline, 3 hours and 1 day
(n ¼ 5 for each group) after NMDA injection. Upon the
completion of MRI, mouse eyes were enucleated, cryosectioned, and stained for assessing retinal layer thickness and cell
death.
RESULTS. Inner retinal cell swelling was hyperintense on
diffusion-weighted images at 3 hours and 1 day after NMDA
injection. The thickened inner retina was also seen in anatomic
MRI and histology. Quantitatively, inner retinal apparent
diffusion coefficient (ADC) decreased approximately 20% at 3
hours and 1 day after NMDA injection (P < 0.05 compared
with baseline), suggesting cell swelling. Systematic injection of
paramagnetic Gd-DTPA did not alter vitreous longitudinal
relaxation time (T1) at baseline or at 3 hours after NMDA
injection. In contrast, vitreous T1 in mice decreased 16 6 6%
(P < 0.05), reflecting retinal vascular leakage at 1 day after
NMDA injection.
CONCLUSIONS. Noninvasive diffusion MRI was performed to
detect retinal cell swelling in vivo. Our results demonstrated
that retinal cell swelling could directly lead to retinal
thickening independent of vascular leakage. (Invest Ophthalmol Vis Sci. 2012;53:2777–2785) DOI:10.1167/iovs.11-8827
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etinal edema impairs vision in millions. It is diagnosed as
abnormal thickening of the retina that is commonly
observed in ischemic and inflammatory diseases.1–4 Retina
edema can be classified as cytotoxic or vasogenic, which
respectively reflects cell swelling induced by volumetric
increase of intracellular water and vascular leakage induced
volumetric increase of extracellular water.5 It is commonly
accepted that vascular leakage is the primary pathway of
retinal edema. However, in ischemic/excitotoxic diseases cell
swelling may develop early or coexist with vascular leakage.6,7
It has also been suggested that the swelling and death of Müller
cells contributes to the development of cystoid macular
edema.4 Thus, cell swelling and vascular leakage may have
different contributions to retinal edema in individual patients.
Noninvasive methods for direct assessment of retinal cell
swelling are lacking. Unlike vascular leakage induced edema
that can be indirectly detected using fluorescein angiography,2,8 retinal cell swelling can be implicated only in certain
patients who develop retinal thickening without vascular
leakage.9 Given the different mechanisms underlying cytotoxic
and vasogenic edema, the capability to differentially assess
retinal cell swelling and vascular leakage is therefore critical to
advance the current disease diagnosis and therapy.
In addition to its detectability, the contribution of cell
swelling to edematous retinal thickening remains an open
question. Knowledge acquired from cerebral diseases suggested that cell swelling may not lead to increased tissue volume if
the blood–tissue barrier, which limits extravasation of blood–
pool water, is intact.10 Instead, cell swelling can develop
through redistribution of extracellular water, accompanying
the ion (primarily Naþ) flux, into the intracellular compartment.10 Since the neural retina comprises a blood–retina
barrier, if the same mechanism applies, cell swelling may not
lead to retinal thickening before the onset of retinal vascular
leakage.
We hypothesize that retinal cell swelling directly causes
retinal thickening. The retina is a thin layer of tissue (200–300
lm thick) located adjacent to vitreous (99% of water
content).11 It continuously experiences a transretinal fluid
flux driven by intraocular pressure gradient from the vitreous
to the choroid.5 This unrestricted extracellular fluid supply
suggests retinal cell swelling may develop without changing
the extracellular water volume. A mouse model of N-methyl-Daspartate (NMDA) excitotoxicity was used to test our
hypothesis. Excessive binding of intravitreally injected NMDA
to NMDA receptors causes overexcitation of neuronal cells
followed by energy failure. The resulting cell swelling and
edematous retinal thickening occur within several hours.12
Due to the absence of NMDA receptors on photoreceptor cells
in the outer retina, NMDA excitotoxicity primarily damages the
inner retina that extends from the nerve fiber layer to the outer
plexiform layer.
In this study, diffusion MRI–derived water apparent
diffusion coefficient (ADC) was measured to evaluate NMDA
excitotoxicity–induced cell swelling in the inner and outer
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retina. Diffusion MRI is a primary clinical imaging method for
assessing neural tissue injury.13 Despite the retinal edemainduced concomitant T1 and T2 changes during the diffusionweighted MRI measurement, the derivation of ADC takes the
ratio of image intensities with and without diffusion weighting,
which essentially performed the automatic normalization of T1
and T2 effects eliminating the commonly seen ‘‘T2 shine
through’’ effect in diffusion-weighted images.13 The measured
ADC is by nature independent of T1 relaxation, T2 relaxation,
or the magnetic field strength.14,15 It has long been recognized
that neuronal cell swelling leads to an ADC decrease.16,17
When cell swelling and vasogenic edema coexist, such as that
observed in ischemia/reperfusion injury,18,19 the relative
contribution of each component at different stages of the
disease confounds the interpretation of the longitudinal
evolution of ADC.
Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA)
enhanced MRI with T1 mapping was used in this study to
evaluate retinal vascular leakage before, at 3 hours, and 1 day
after NMDA treatment. Gadolinium is a paramagnetic ion that
reduces 1H T1 of surrounding water molecules. The chelated
Gd-DTPA has limited permeability through intact blood–brain
barrier or blood–retina barrier. In CNS diseases such as
multiple sclerosis (MS), the Gd-DTPA from the blood pool into
perivascular tissue through the damaged blood–brain barrier in
active lesions results in signal enhancement on T1-weighted
images.20–22 The sensitivity of this technique to MS lesions is
improved by administering a higher dose of Gd-DTPA and
delayed image acquisition23,24; for example, it reached a 95%
detection rate for MS lesions when MR images were acquired at
20 minutes after a triple dose (0.3 mmol/kg) of Gd-DTPA.24 In
retinal diseases such as diabetic retinopathy25 and macular
edema,26 the leakage of Gd-DTPA into avascular posterior
vitreous caused local enhancement of the T1-weighted signal.
The Gd-DTPA–enhanced MRI-detected retinal vascular leakage
was confirmed by histology27 or electron microscopy.28 Our
recent work showed that retinal vascular leakage in rd1 mice
resulted in a progressive increase of vitreous signal within the
first 30 minutes after injection of 1.0 mmol/kg Gd-DTPA.29
Unfortunately, the exact sensitivity of this MRI technique to
retinal vascular leakage, as compared with standard fluorescein
angiography and histological methods, has not been defined
yet. Based on the previous work of our group and others, we
used a high dose of Gd-DTPA (1.0 mmol/kg, 10-folds the
standard dose) and delayed image acquisition (between 30 and
45 minutes after Gd-DTPA injection) to optimize MRI
sensitivity against retinal vascular leakage.

METHODS
NMDA Animal Model
All animal experiments were performed according to protocols
approved by the Animal Studies Committee at Washington University
and were in adherence to the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research.
A total of 71 3- to 4-month-old male C57BL/6 mice were used.
Normal mice (n ¼ 5) were used to determine the baseline parameters.
Other mice were intravitreally injected with 0.5 lL of 5 mM (equivalent
to 2.5 nmol) NMDA or sham-injected with 0.5 lL of saline. Diffusion
MRI was performed at 3 hours (n ¼ 8 for NMDA group vs. 5 for sham
group), 1 day (n ¼ 8 vs. 7), 3 days (n ¼ 8 vs. 5) or 7 days (n ¼ 5 vs. 5)
after intravitreal injection. A separate group of mice was used to assess
the development of NMDA excitotoxicity–induced retinal vascular
leakage. The differences in vitreous longitudinal relaxation time (T1)
after Gd-DTPA injection in normal mice (n ¼ 5), and in mice at 3 hours
(n ¼ 5), and 1 day (n ¼ 5) after NMDA injection were examined.
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Intravitreal Injection Protocol
Intravitreal injection was performed according to reported procedures
with some modifications.30 Mice were anesthetized by inhalation of
1.5–3% isoflurane mixed with oxygen. A drop of topical antibiotics was
applied to the left eye. A 34-gauge sharp needle was inserted into the
posterior vitreous (1.5 mm depth) at approximately 1 mm posterior to
the limbus. The other end of the needle was connected to a
microinjection pump (World Precision Instruments, Sarasota, FL). A
total of 0.5 lL 5 mM (equivalent to 2.5 nmol) NMDA or saline was
injected into the vitreous within 15 seconds. The needle was kept in
the vitreous for 1 extra minute and then was slowly pulled out. Finally,
a drop of antibiotic gel was applied to the left eye.
The injection volume was selected to avoid distortion of the globe
that was frequently observed after injection of >1 lL fluid. The 0.5 lL
fluid occupied approximately 10% of mouse vitreous volume (4.3 6
0.6 lL, n ¼ 6) as determined by MRI (voxel size ¼ 100 · 100 · 100 lm3
or 1 nL; Kaplan HJ, et al. IOVS 2010;43:ARVO E-Abstract 4414).

MRI
MRI was performed on a commercial MRI system scanner (Varian
11.74T UNITY-INOVA spectrometer/scanner; Varian Associates, Palo
Alto, CA) using our previously reported procedure. Mice were
anesthetized by intraperitoneal injection of ketamine (87 mg/kg) and
xylazine (13 mg/kg) followed by constant subcutaneous infusion of
ketamine (54 mg/kg/h)/xylazine (4 mg/kg/h). Animal body temperature was maintained at 378C and its respiration was monitored using a
small animal heating and monitoring system (SA Instruments, Stony
Brook, NY). An active-decoupled saddle volume coil was used for
radiofrequency (RF) transmission. An actively decoupled surface coil
(diameter ¼ 1 cm) was placed on top of the left eye for receiving the
MR signal. All images were acquired on a nasal–temporal slice that
bisects the eye through the optic nerve head.
Diffusion MRI was used to assess NMDA excitotoxicity–induced
retinal cell injury. Three orthogonal diffusion gradients were applied in
directions parallel to and in- and out-of-plane perpendicular to the axis
of the optic nerve. In each direction, a pair of diffusion-weighted
images was acquired with positive and negative diffusion gradients to
minimize the background magnetic field gradient effect on the
diffusion measurement. Acquisition parameters were: slice thickness
400 lm; field-of-view 12 · 12 mm2; data matrix 256 · 256 (zero filled
to 512 · 512); in-plane resolution 47 · 47 lm2; number of averages 1;
repetition time (TR) 2.0 s; echo time (TE) 34 ms; diffusion gradient on
time (d) 5 ms; duration time between two diffusion gradients (D) 15
ms; b-values 0 and 954 s/mm2; acquisition time 1 hour.
Gd-DTPA–enhanced MRI was used to assess the development of
retinal vascular leakage in NMDA-injected mice. Two sets of T1weighted images of mouse eye were acquired before and 30 minutes
after a bolus injection of Gd-DTPA (1 mmol/kg) through an
intraperitoneal catheter. Acquisition parameters were: slice thickness
400 lm; field-of-view 6 · 6 mm2; data matrix 32 · 64 (the resolution
was higher in the direction parallel to the optic nerve, zero filled to 64
· 64); in-plane resolution 188 · 94 lm2; TR (number of averages) 0.3 s
(8), 0.8 s (4), 2.0 s (2), 6.0 s (1), 16.0 s (1); TE 16 ms; acquisition time
17 minutes.
All animals underwent a single diffusion or Gd-DTPA–enhanced
MRI measurement. Upon the conclusion of MRI, mice were euthanized
and eyes were enucleated for histology.

MR Data Analysis
Diffusion-weighted and T1-weighted MR images were processed using
previously described methods to determine ADC and T1 maps of the
mouse eye.31
NMDA-induced cell injury in the inner and outer retina was
assessed using ADC. Segmentation of the inner and outer retina was
performed following a previously described procedure with minor
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FIGURE 1. Representative nondiffusion-weighted (left) and diffusion-weighted (right) MR images of mouse eyes at 3 hours after saline injection (a),
or at 3 hours (b) and 1 day (c) after NMDA injection. On nondiffusion-weighted images, the anterior chamber (AC), lens (L), vitreous (V), and sclera
(S) are clearly identified. Retina/choroid layers (R/C) were bright on diffusion weighting and exhibited multiple signal intensity layers on
nondiffusion-weighted images. At 3 hours and 1 day after intravitreal injection of NMDA, a hyperintense inner retina layer appeared in diffusionweighted images, reflecting decreased diffusivity. On nondiffusion images of the same mouse eyes, more MR-detected layers in retina are visually
discernible.
adjustments (see Figs. 3a and 3b in the following text).31 First, the
retina and choroid layers were identified by the hyperintense signal on
diffusion-weighted images. The retina and choroid were determined as
the region with signal > mean 6 3SD of vitreous and sclera signal.
Second, the choroid was manually segmented on nondiffusionweighted images as the outermost hyperintense layer of the retina/
choroid layers. The remaining tissue was considered as the MRIdetected retina. Finally, the outermost hypointense retinal layer on
nondiffusion-weighted images was manually segmented and assigned
as the outer retina that comprises photoreceptor cell nuclei, inner and
outer segments. All other MRI-detected retinal layers were assigned to
the inner retina that extends from the nerve fiber layer to the outer
plexiform layer. Due to the absence of MR signal contrast at the
peripheral retina, we used our previously reported protocol to define
the region-of-interest (ROI) analyzing retinal ADC.31 Specifically, two
central retinal segments, located between 250 and 750 lm away from
the optic nerve head, were used to determine the mean retinal ADC.

The MRI-determined inner and outer retinal thickness was estimated as
the mean thickness in the two segments.
To quantify vitreous T1 on the calculated T1-map, the ROI covering
the entire vitreous space was defined. The mean T1 in this ROI was
used for interanimal data comparison.

Histology
Eyes were enucleated, flash-frozen, and sectioned (8 lm thick). Tissue
sections were stained with hematoxylin and eosin (H&E) for analysis of
the retinal thickness and cell loss, and stained with terminal
deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) for
analysis of cell apoptosis. Only those sections cut through the optic
nerve head and perpendicular to the retina were selected for data
analysis. The thickness of the inner and outer retina on H&E–stained
slices was measured in the central retina region corresponding to that
used for ADC analysis. Because sporadic tissue loss had occurred
during the TUNEL staining preparation, the exactly identical ROI for

FIGURE 2. Assignment of MR-detected retinal cell layers based on the MRI and histology-measured layer thickness. The R/C layers on nondiffusionweighted images (left) and the corresponding regions on H&E–stained retinal sections (right) in mice at 1 day after saline (a) and NMDA (b)
injection are shown. The bright layer adjacent to the sclera was assigned to the choroid. The dark retinal layer adjacent to the choroid was assigned
to the outer retina. The remaining retinal layers, four in mice at 3 hours and 1 day after NMDA injection and two in all other mice, were assigned to
the inner retina. MRI and histology-quantified thickness of retinal layers and the choroid after saline (c) or NMDA (d) injection is shown. Each data
point represents the average of mice at 3 hours and 1 day after injection. Compared with histology, MRI detected similar inner retinal thickness,
underestimated the outer retinal thickness, and overestimated the choroid thickness in all mice. *P < 0.05 compared with histology-determined
layer thickness. Data were presented as mean 6 SD. NFL, nerve fiber layer; GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear
layer; OPL, outer plexiform layer; ONL, outer nuclear layer of photoreceptor cells; IS/OS, inner and outer segments of photoreceptor cells; RPE,
retinal pigment epithelium.
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overall significance of P < 0.05 was attained by ANOVA, comparisons
between the means were performed using the Freeman–Tukey test.
Paired Student’s t-test was used to test the difference of vitreous T1
before and after Gd-DTPA treatment. A statistically significant
difference was defined by P < 0.05.

RESULTS
MRI Detected Abnormal Inner Retinal Signal at 3
Hours and 1 Day after NMDA Injection
Figure 1 shows representative diffusion- and nondiffusionweighted MR images of mouse eyes. In nondiffusion-weighted
images, three MR signal intensity defined layers were seen in
the retina of normal mice (Figs. 1a, 2a). Both lens and sclera
appeared dark. In contrast, the anterior chamber and vitreous
were bright. In diffusion-weighted images (b-value ¼ 954 s/
mm2), the vitreous and anterior chambers were nearly invisible
because of fast water diffusion in these compartments. The
retina/choroid layers appeared bright because of restricted
water diffusion in these tissues.
At 3 hours and 1 day after NMDA injection, diffusionweighted images detected abnormal hyperintense signal in the
inner retina, suggestive of reduced water diffusivity. Nondiffusion-weighted images showed two more MR-detected
retinal layers in NMDA-treated mice than that in saline-injected
mice, indicating retinal thickening (Figs. 1b, 1c, 2b).

Inner Retinal Thickness Transiently Increased at 3
Hours and 1 Day after NMDA Injection

FIGURE 3. Histology-determined inner and outer retina thickness of
normal and NMDA-injured mice. H&E–stained retinal sections of mice
at 1 day after saline or NMDA injection (a) show substantially increased
retina thickness in NMDA-treated mice. Arrows indicate the optic
nerve head. Scale bar: 100 lm. Quantitative measurements showed
increased inner retinal thickness at 3 hours and 1 day after NMDA
injection (b). The outer retinal thickness remained unchanged in all
mice (c). *P < 0.05 compared with saline-injected mice at the same
time point and normal mice at baseline. Data were presented as mean
6 SD.
ADC and thickness measurement by MRI could not be obtained
without encountering tissue voids by histology. Thus, four 200-lmwide central retinal segments from two adjacent frozen-tissue sections,
a subregion representing the largest area allowing a consistent
localization among tissues within the MRI analysis region, were used
for counting necrotic or apoptotic cells.

Statistics
All statistical analyses were performed using commercial software (SAS
software; SAS Institute, Cary, NC). Quantitative data are expressed as
mean 6 SD. For comparisons between two experimental groups, the
significance of the difference between the means was calculated.
Two-way ANOVA was used to test the difference of: (1) the inner or
outer retinal ADC for NMDA- versus saline-injected mice at different
time points; (2) the inner or outer retinal thickness for NMDA- versus
saline-injected mice at different time points; and (3) the number of
necrotic or apoptotic cells among different retinal nuclear layers at
different time points. One-way ANOVA was used to test the difference
of Gd-DTPA–induced T1 shortening among normal mice, NMDAinjected mice at 3 hours, and NMDA-injected mice at 1 day. When

Figures 2a and 2b show the assignment of MRI-detected
retinal/choroid layers using MRI and histology-measured retinal
thickness. Based on our previous reports,29,31,32 the outmost
MR-detected retina/choroid layer, that is, the bright layer
adjacent to sclera, was assigned as the choroid. The layer
adjacent to the choroid was assigned as outer retinal
photoreceptor cells comprising the outer nuclear layer and
the inner and outer segments. The remaining MRI-detected
layers were assigned as the inner retina. The assigned inner
retina was confirmed by the comparable MRI and histologydetermined inner retinal thickness in both saline- and NMDAtreated mice (Figs. 2c, 2d). The thickness of the MRI-detected
outer retina was underestimated due to the partial volumeeffect–induced overestimation of the thickness of MRI-detected
choroid.31
Histological analysis showed NMDA injection acutely
caused an approximately 50% increase of inner retinal
thickness, reaching 170 6 17 lm at 3 hours and 163 6 16
lm at 1 day (P < 0.05 compared with saline-injected mice).
From 3 days after NMDA injection, the inner retinal thickness
recovered to its normal value of 115 6 15 lm (Figs. 3a, 3b).
The outer retinal thickness remained unchanged at all time
points after NMDA injection (Fig. 3c).

Inner Retinal ADC Transiently Decreased at 3
Hours and 1 Day after NMDA Injection
Figure 4 shows diffusion MRI quantified inner and outer retinal
ADC. The inner retinal ADC was 0.51 6 0.07 lm2/ms at
baseline. After NMDA injection, the inner retinal ADC
decreased by approximately 20%, reducing to 0.40 6 0.02
lm2/ms at 3 hours and 0.39 6 0.05 lm2/ms at 1 day. From 3
days after NMDA injection, the inner retinal ADC recovered to
baseline values. In contrast, the outer retinal ADC remained
unchanged after NMDA injection. In saline-injected mice, both
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outer retina of NMDA-treated mice or in the entire retina of
normal and saline-injected mice.
Retinal cell apoptosis was assessed by TUNEL staining. As
early as 3 hours after NMDA injection, TUNEL-positive
apoptotic cells were observed in the inner retina (Fig. 6c).
The number of apoptotic cells peaked at 1 day and decreased
close to zero at 3 and 7 days (Fig. 6d). Sporadic apoptotic cells
were detected in the outer retinal photoreceptor cells of
NMDA-treated mice, which agreed with previous reports.33,34
No apoptotic cells were detected in the retina of normal and
saline-injected mice.

DISCUSSION

FIGURE 4. Diffusion MRI determined inner and outer retinal ADC of
normal and NMDA-injured mice. Representative ADC maps of mouse
retina at 1 day after saline or NMDA injection were shown (a). The
inner retinal ADC transiently reduced in mice at 3 hours and 1 day after
NMDA injection (b); the outer retinal ADC remained unchanged after
NMDA injection (c). *P < 0.05 compared with saline-injected mice.
Data were presented as mean 6 SD.

inner and outer retinal ADC remained unchanged at all time
points.

Retinal Vascular Leakage Was Observed at 1 Day,
but Not at 3 Hours, after NMDA Injection
Retinal vascular leakage was evaluated by Gd-DTPA–enhanced
MRI (Fig. 5). Gd-DTPA treatment did not cause significant
changes of the vitreous T1 in normal mice (-0 6 4%) or mice
at 3 hours after NMDA injection (-4 6 3%). However, in mice
at 1 day after NMDA injection, Gd-DTPA treatment changed the
vitreous T1 by -16 6 6% (P < 0.05 compared with before GdDTPA treatment) due to leakage of Gd-DTPA into the avascular
vitreous.25

NMDA Excitotoxicity Causes Inner Retinal Cell
Necrosis and Swelling
Excitotoxicity-induced inner retinal cell swelling was reflected
by the ensuing retinal cell necrosis on H&E–stained slides (Fig.
6a). The number of necrotic cells peaked at 3 hours and 1 day
after NMDA injection, then rapidly decreased close to zero
from 3 to 7 days (Fig. 6b). No necrotic cell was observed in the

Our results demonstrated the capability of in vivo diffusion
MRI to noninvasively assess retinal cell swelling in the NMDA
mouse model. The cytotoxic retinal edema induced by
intravitreal injection of NMDA resulted in transient inner
retinal thickening and ADC decrease. Inner retinal thickening
with ADC decrease was observed at 3 hours after NMDA
injection, prior to retinal vascular leakage. This decreased ADC
was not masked by the potential presence of vasogenic edema
resulting from the onset of vascular leakage at 1 day after
NMDA injection. Thus, our finding suggests that retinal cell
swelling, unlike its cerebral counterpart, can directly cause
retinal thickening independent of retinal vascular leakage.
The NMDA mouse model was selected in this study to take
advantage of NMDA excitotoxicity-induced layer-specific injury
in the inner retina.12 Specifically, intravitreal injection of
NMDA acutely causes the overexcitation of inner retinal
neuronal cells due to its excessive binding to NMDA receptors.
Müller cell swelling may also occur due to intracellular
overloading of Kþ and glutamate that are released by
overexcited neuronal cells.35 However, outer retinal photoreceptor cells that do not express NMDA receptors, as well as
retinal vasculature that comprises nonexcitable cells, are not
directly affected by NMDA.36 Thus, the NMDA mouse model is
ideal to evaluate contribution of cell swelling to edematous
retinal thickening.
The present study is the first in vivo investigation of layerspecific retinal cell swelling using diffusion MRI. The image
resolution used (47 · 47 lm) is among the highest resolution
reported in the literature.29,31,37 Although five pixels across the
200-lm-thick retina could not resolve individual retinal
anatomic layers (Figs. 2a, 2b), our results showed that it is
sufficient to differentially detect inner retinal cell swelling from
the outer retina in vivo. Using the same imaging parameters
(e.g., TR and TE) as those used in our previous report,31 the
observed inner and outer retinal ADC in normal mice were
consistent between the two studies.31 In NMDA-injured mice,
an approximately 20% decrease of inner retinal ADC was
detected at 3 hours and 1 day after NMDA injection, reflecting
the acute development of cell swelling in the inner retina. In
agreement with MRI findings, histology analysis showed that
the inner retinal cell necrosis, which typically developed after
cell swelling,38 also peaked at 3 hours and 1 day after NMDA
injection. In the outer retina, however, no substantial change in
MRI-determined ADC or histology-delineated cell viability was
observed after NMDA injection. Thus, our results demonstrated
that diffusion MRI may be used to detect layer-specific retinal
injury in vivo.
Retinal vascular leakage was assessed by Gd-DTPA–enhanced MRI. Gadolinium ion, Gd3þ, is paramagnetic, which
reduces the T1 of surrounding water. After intraperitoneal
injection, Gd-DTPA is absorbed into the blood pool and
delivered to the retina through circulation. Under normal
conditions, Gd-DTPA does not penetrate the intact blood–
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FIGURE 5. Gd-DTPA–enhanced MRI detected vitreous T1 in mouse eyes at baseline (a), 3 hours (b) or 1 day (c) after NMDA injection. Top images:
representative T1 maps of each mouse eye acquired before (left) and at 30 minutes after (right) intraperitoneal injection of Gd-DTPA. Bottom graphs:
quantified vitreous T1 before and after Gd-DTPA treatment. Each pair of open symbols, linked by a dashed line, represents the vitreous T1 of the eye
measured pre- and postintravenous injection of Gd-DTPA from each individual mouse. The filled symbols represent the averaged vitreous T1 of all five
mice. Statistical analysis showed the leaked Gd-DTPA resulting in a substantial decrease of vitreous T1 (DT1 ¼ -16 6 6%) in mice at 1 day after NMDA
injection (d). In all mice, the T1 of anterior chamber was reduced after Gd-DTPA treatment due to its fluid supply from the blood pool that contains
Gd-DTPA. AC, anterior chamber; V, vitreous; Pre-, before Gd-DTPA treatment; Post-, 30 minutes after Gd-DTPA treatment. *P < 0.05 compared with
vitreous T1 of the same mice before Gd-DTPA treatment. **P < 0.01 compared with DT1 of other groups. Data were presented as mean 6 SD.

retinal barrier into the avascular vitreous. After blood–retinal
barrier breakdown, the leakage of Gd-DTPA from the retinal
vessels into the vitreous, as well as the diffusion of leaked GdDTPA from the choroid vascular bed to the vitreous, results in
shortening of the vitreous T1 that can be quantified by
MRI.25,29,39,40
Our results showed that retinal thickening developed
before retinal vascular leakage in NMDA-injured mice. De-

creased inner retinal ADC was observed at both 3 hours and 1
day after NMDA injection, reflecting inner retinal cell swelling.
At 3 hours after NMDA injection, the vitreous T1 was not
changed after systematic Gd-DTPA injection, reflecting the
integrity of blood–retina barrier. Thus, the substantial thickening of the inner retina suggests a dominant contribution of cell
swelling at this early time point. This is distinct from that
observed in brain injury, where a volumetric increase of

FIGURE 6. Histology analysis of NMDA excitotoxicity induced cell necrosis and apoptosis in different retinal cell layers. H&E staining shows
necrotic cells (arrows) that stained with eosinophilic, pink cytoplasm and pyknotic (shrunken), purple nuclei in GCL (e.g., middle insert) and INL
(e.g., right insert) (a). TUNEL staining shows apoptotic cells in green color (b). Quantitative analysis showed the number of necrotic (c) and
apoptotic (d) cells in GCL and INL peaked at 3 hours and 1 days. Sporadic apoptotic cells, but no necrotic cells, were observed in the ONL. *P <
0.05 compared with 3 and 7 days after NMDA injection. Data were presented as mean 6 SD.
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cerebral tissue is primarily caused by vascular leakage instead
of cell swelling.10 In mice at 1 day after NMDA injection,
however, Gd-DTPA treatment caused a 16 6 6% decrease of
the vitreous T1, indicating the presence of retinal vascular
leakage. The coexisting vascular leakage and cell swelling at
this time point may jointly contribute to the inner retinal
thickening.
The different effect of cell swelling on retinal and cerebral
tissue volume might be attributed to the different external fluid
supply to these tissues. Excitotoxicity-induced neuron cell
swelling is developed by intracellular sequestration of water
with Naþ influx.10 In the brain, the blood pool is the only
source of external fluid supply. The fluid movement from the
blood pool to extracellular space is tightly controlled by the
blood–brain barrier, consisting of tight junctions around
capillaries, largely impermeable to ions and fluids.41 If the
blood–brain barrier is intact, cerebral cell swelling will develop
by redistributing extracellular water into intracellular space
without increasing the brain volume.10 In contrast, the retina
experiences sustained transretinal fluid flux, driven by
hydrostatic pressure gradient, from the vitreous to the
choroid.5 When the blood–retinal barrier is intact, the
extracellular water is likely replenished by the transretinal
fluid flux and/or diffusion, resulting in an overall increase of
the retinal fluid volume (i.e., retinal thickening). This
mechanism of cell swelling–induced retinal thickening is
consistent with previous findings of acutely developed retinal
thickening, retina cell swelling, and extracellular space
shrinkage in whole-mount guinea pig retina preparation
exposed to 1 mM L-glutamate.42 The unchanged retinal
thickness before L-glutamate exposure, the reduced extracellular space after L-glutamate exposure, together with the
absence of blood hydrostatic pressure to drive vascular leakage
suggested vasogenic edema did not contribute to the acute
thickening of whole-mount retina. Thus, it is plausible that the
observed cell swelling is the primary cause of L-glutamate
excitotoxicity-induced retinal thickening.
The increased inner retinal thickness at 3 hours and 1 day
after NMDA injection is in agreement with previous reports
that excitotoxicity leads to acute thickening and chronic
thinning of the inner retina.12,43 The acute retinal thickening
was, at least partly, caused by the swelling of injured cells.42,44
The progressive death/loss of injured cells12,26,27 caused inner
retinal thickness thinning has been observed at 7 days after
NMDA injection.33,45–47 NMDA-decreased retinal thickness was
shown to be dose dependent in rats.33 Despite the NMDA dose
effect on mouse retinal thickness has not been investigated in
previous studies,30,34,43,48–51 it has been shown that at least 30
nmol NMDA is needed in mice to cause significant death of
retinal ganglion cells by 7 days after NMDA injection.50
Accordingly, the low dose of NMDA (2.5 nmol) used in this
study probably did not substantially damage retinal cells to
cause significant retinal thinning at 7 days after NMDA
injection.
In this study, the NMDA dose was selected to induce retinal
cell swelling while minimizing the extent of cell death, which
could potentially cause an ADC increase, complicating data
interpretation.52 The 0.5 lL injection volume was selected to
avoid the risk of elevated intraocular pressure–induced retinal
mechanical injury. Our results showed that retinal ADC was
not altered after injection of 0.5 lL of saline (Fig. 4).
The current study has several limitations. First, excitotoxicity-induced cell swelling is not a major cause of retinal edema
in patients. The development of cell swelling in retinal edema
commonly occurred in ischemic and inflammatory diseases.6,53
Since diffusion MRI–derived ADC is a marker of cell swelling
despite its origin, selection of the NMDA mouse model does
not undermine the potential of diffusion MRI to detect cell
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swelling in other retinal diseases. Second, this study did not
directly evaluate glial cell swelling that has been documented
in previous studies.35,42 Third, Gd-DTPA–enhanced MRI was
performed on control and NMDA-injured mice at 3 hours and 1
day after exposure. Since our results showed retinal vascular
leakage occurred at 1 day after NMDA injection, the selected
study groups sufficiently support that retinal cell swelling is
the dominant contributor of retinal thickening at 3 hours after
NMDA injection. However, it is unclear whether vascular
leakage will continue at later time points (e.g., at 3 and 7 days)
when cell swelling and apoptosis reduce and ADC returns to
its normal value. Further investigation is needed in the future
for a better understanding of the progression of retinal edema.
Finally, quantitative ADC measurement requires four images,
that is, three diffusion-weighted images oriented orthogonal to
each other and one nondiffusion-weighted image. For a fast
screening of disease-induced cell swelling, a diffusion-weighted
image along a single direction, a 75% saving in acquisition time,
may be acquired to reflect the effect without quantifying ADC
(Fig. 1).
In summary, we used diffusion MRI–derived ADC to detect
retinal cell swelling in the edematous retina using the NMDA
mouse model. Our results revealed that retinal cell swelling can
directly contribute to retinal thickening, a mechanism different
from that observed in cerebral diseases. Compared with
existing methods to detect retinal vascular leakage and retinal
thickening, diffusion MRI assessment of cell swelling provides
critical and complementary information for investigating the
pathomechanism of retinal edema.
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